Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF CELL PROLIFERATION |
171 |
1496 |
1.655e-69 |
7.702e-66 |
2 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
187 |
1929 |
4.398e-65 |
1.023e-61 |
3 |
REGULATION OF CELL DEATH |
161 |
1472 |
3.709e-62 |
5.752e-59 |
4 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
176 |
1848 |
1.823e-59 |
2.121e-56 |
5 |
IMMUNE SYSTEM PROCESS |
180 |
1984 |
8.89e-58 |
8.273e-55 |
6 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
151 |
1395 |
3.037e-57 |
2.355e-54 |
7 |
POSITIVE REGULATION OF GENE EXPRESSION |
164 |
1733 |
1.928e-54 |
1.282e-51 |
8 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
167 |
1805 |
3.519e-54 |
2.047e-51 |
9 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
146 |
1381 |
7.934e-54 |
4.102e-51 |
10 |
RESPONSE TO ENDOGENOUS STIMULUS |
148 |
1450 |
1.137e-52 |
5.289e-50 |
11 |
NEGATIVE REGULATION OF CELL DEATH |
115 |
872 |
2.042e-51 |
8.636e-49 |
12 |
LOCOMOTION |
126 |
1114 |
4.547e-49 |
1.763e-46 |
13 |
RESPONSE TO EXTERNAL STIMULUS |
160 |
1821 |
1.412e-48 |
5.054e-46 |
14 |
REGULATION OF CELL DIFFERENTIATION |
144 |
1492 |
4.389e-48 |
1.459e-45 |
15 |
RESPONSE TO LIPID |
110 |
888 |
2.473e-46 |
7.672e-44 |
16 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
150 |
1672 |
2.72e-46 |
7.911e-44 |
17 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
122 |
1142 |
9.639e-45 |
2.638e-42 |
18 |
POSITIVE REGULATION OF CELL COMMUNICATION |
141 |
1532 |
1.613e-44 |
4.169e-42 |
19 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
127 |
1275 |
2.194e-43 |
5.372e-41 |
20 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
101 |
799 |
3.586e-43 |
8.344e-41 |
21 |
REGULATION OF RESPONSE TO STRESS |
136 |
1468 |
4.145e-43 |
9.183e-41 |
22 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
150 |
1784 |
8.416e-43 |
1.78e-40 |
23 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
107 |
917 |
1.611e-42 |
3.26e-40 |
24 |
REGULATION OF IMMUNE SYSTEM PROCESS |
132 |
1403 |
1.82e-42 |
3.529e-40 |
25 |
POSITIVE REGULATION OF CELL PROLIFERATION |
101 |
814 |
1.955e-42 |
3.639e-40 |
26 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
136 |
1492 |
2.619e-42 |
4.687e-40 |
27 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
104 |
876 |
5.772e-42 |
9.946e-40 |
28 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
143 |
1656 |
6.255e-42 |
1.039e-39 |
29 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
141 |
1618 |
9.692e-42 |
1.555e-39 |
30 |
CELL MOTILITY |
101 |
835 |
1.967e-41 |
2.952e-39 |
31 |
LOCALIZATION OF CELL |
101 |
835 |
1.967e-41 |
2.952e-39 |
32 |
TISSUE DEVELOPMENT |
135 |
1518 |
9.086e-41 |
1.321e-38 |
33 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
96 |
771 |
2.181e-40 |
3.075e-38 |
34 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
143 |
1710 |
2.652e-40 |
3.63e-38 |
35 |
POSITIVE REGULATION OF LOCOMOTION |
72 |
420 |
1.867e-39 |
2.482e-37 |
36 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
105 |
983 |
3.694e-38 |
4.775e-36 |
37 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
143 |
1791 |
5.457e-38 |
6.862e-36 |
38 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
107 |
1036 |
1.411e-37 |
1.683e-35 |
39 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
107 |
1036 |
1.411e-37 |
1.683e-35 |
40 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
105 |
1004 |
2.497e-37 |
2.905e-35 |
41 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
95 |
823 |
3.583e-37 |
4.066e-35 |
42 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
122 |
1360 |
6.678e-37 |
7.399e-35 |
43 |
IMMUNE SYSTEM DEVELOPMENT |
80 |
582 |
1.245e-36 |
1.347e-34 |
44 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
104 |
1008 |
1.965e-36 |
2.077e-34 |
45 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
109 |
1135 |
2.115e-35 |
2.187e-33 |
46 |
IMMUNE RESPONSE |
107 |
1100 |
3.237e-35 |
3.275e-33 |
47 |
REGULATION OF CELL ADHESION |
81 |
629 |
5.272e-35 |
5.219e-33 |
48 |
DEFENSE RESPONSE |
113 |
1231 |
6.226e-35 |
6.035e-33 |
49 |
CELL ACTIVATION |
77 |
568 |
8.101e-35 |
7.693e-33 |
50 |
RESPONSE TO ABIOTIC STIMULUS |
102 |
1024 |
2.222e-34 |
2.068e-32 |
51 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
81 |
643 |
2.626e-34 |
2.395e-32 |
52 |
RESPONSE TO HORMONE |
95 |
893 |
3.043e-34 |
2.723e-32 |
53 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
88 |
788 |
2.956e-33 |
2.547e-31 |
54 |
CIRCULATORY SYSTEM DEVELOPMENT |
88 |
788 |
2.956e-33 |
2.547e-31 |
55 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
92 |
867 |
4.827e-33 |
4.084e-31 |
56 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
108 |
1192 |
8.464e-33 |
7.033e-31 |
57 |
INFLAMMATORY RESPONSE |
67 |
454 |
1.434e-32 |
1.17e-30 |
58 |
RESPONSE TO WOUNDING |
74 |
563 |
1.503e-32 |
1.206e-30 |
59 |
CELL DEATH |
98 |
1001 |
2.318e-32 |
1.828e-30 |
60 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
57 |
321 |
3.996e-32 |
3.099e-30 |
61 |
RESPONSE TO CYTOKINE |
82 |
714 |
8.094e-32 |
6.174e-30 |
62 |
NEGATIVE REGULATION OF GENE EXPRESSION |
120 |
1493 |
1.211e-31 |
9.086e-30 |
63 |
REGULATION OF CYTOKINE PRODUCTION |
72 |
563 |
6.779e-31 |
5.007e-29 |
64 |
POSITIVE REGULATION OF CELL DEATH |
74 |
605 |
1.783e-30 |
1.296e-28 |
65 |
REGULATION OF TRANSPORT |
131 |
1804 |
2.656e-30 |
1.901e-28 |
66 |
RESPONSE TO BIOTIC STIMULUS |
89 |
886 |
3.858e-30 |
2.72e-28 |
67 |
WOUND HEALING |
65 |
470 |
6.549e-30 |
4.548e-28 |
68 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
118 |
1518 |
9.687e-30 |
6.532e-28 |
69 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
84 |
801 |
9.596e-30 |
6.532e-28 |
70 |
RESPONSE TO NITROGEN COMPOUND |
87 |
859 |
1.037e-29 |
6.896e-28 |
71 |
ORGAN MORPHOGENESIS |
86 |
841 |
1.15e-29 |
7.535e-28 |
72 |
LEUKOCYTE ACTIVATION |
61 |
414 |
1.219e-29 |
7.881e-28 |
73 |
LEUKOCYTE DIFFERENTIATION |
52 |
292 |
2.01e-29 |
1.281e-27 |
74 |
LEUKOCYTE MIGRATION |
49 |
259 |
4.964e-29 |
3.121e-27 |
75 |
VASCULATURE DEVELOPMENT |
63 |
469 |
2.838e-28 |
1.761e-26 |
76 |
CELLULAR RESPONSE TO LIPID |
62 |
457 |
4.495e-28 |
2.752e-26 |
77 |
LYMPHOCYTE ACTIVATION |
54 |
342 |
8.018e-28 |
4.845e-26 |
78 |
RESPONSE TO BACTERIUM |
66 |
528 |
9.515e-28 |
5.676e-26 |
79 |
RESPONSE TO STEROID HORMONE |
64 |
497 |
1.176e-27 |
6.924e-26 |
80 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
51 |
304 |
1.357e-27 |
7.89e-26 |
81 |
EPITHELIUM DEVELOPMENT |
88 |
945 |
2.164e-27 |
1.243e-25 |
82 |
REGULATION OF MAPK CASCADE |
73 |
660 |
2.841e-27 |
1.612e-25 |
83 |
INTRACELLULAR SIGNAL TRANSDUCTION |
116 |
1572 |
3.423e-27 |
1.919e-25 |
84 |
REGULATION OF CELL DEVELOPMENT |
82 |
836 |
5.035e-27 |
2.789e-25 |
85 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
86 |
926 |
1.122e-26 |
6.14e-25 |
86 |
BIOLOGICAL ADHESION |
91 |
1032 |
1.356e-26 |
7.336e-25 |
87 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
90 |
1021 |
2.761e-26 |
1.477e-24 |
88 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
112 |
1517 |
3.221e-26 |
1.692e-24 |
89 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
96 |
1152 |
3.236e-26 |
1.692e-24 |
90 |
REGULATION OF KINASE ACTIVITY |
77 |
776 |
1.087e-25 |
5.622e-24 |
91 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
75 |
740 |
1.339e-25 |
6.847e-24 |
92 |
SINGLE ORGANISM CELL ADHESION |
59 |
459 |
1.723e-25 |
8.716e-24 |
93 |
POSITIVE REGULATION OF TRANSPORT |
84 |
936 |
4.93e-25 |
2.467e-23 |
94 |
REGULATION OF PEPTIDASE ACTIVITY |
54 |
392 |
7.504e-25 |
3.714e-23 |
95 |
RESPONSE TO ALCOHOL |
52 |
362 |
7.974e-25 |
3.905e-23 |
96 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
41 |
213 |
9.611e-25 |
4.659e-23 |
97 |
RESPONSE TO GROWTH FACTOR |
59 |
475 |
1.045e-24 |
5.013e-23 |
98 |
REGULATION OF HYDROLASE ACTIVITY |
101 |
1327 |
1.526e-24 |
7.247e-23 |
99 |
LEUKOCYTE CELL CELL ADHESION |
44 |
255 |
1.929e-24 |
9.067e-23 |
100 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
58 |
465 |
2.16e-24 |
1.005e-22 |
101 |
TISSUE MORPHOGENESIS |
62 |
533 |
2.203e-24 |
1.015e-22 |
102 |
BLOOD VESSEL MORPHOGENESIS |
51 |
364 |
7.433e-24 |
3.391e-22 |
103 |
POSITIVE REGULATION OF PEPTIDASE ACTIVITY |
35 |
154 |
7.896e-24 |
3.567e-22 |
104 |
REGULATION OF CELL CELL ADHESION |
52 |
380 |
8.036e-24 |
3.595e-22 |
105 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
89 |
1087 |
9.938e-24 |
4.404e-22 |
106 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
65 |
606 |
1.433e-23 |
6.291e-22 |
107 |
REGULATION OF DEFENSE RESPONSE |
73 |
759 |
1.533e-23 |
6.666e-22 |
108 |
REGULATION OF TRANSFERASE ACTIVITY |
82 |
946 |
1.92e-23 |
8.273e-22 |
109 |
CELL DEVELOPMENT |
103 |
1426 |
2.774e-23 |
1.184e-21 |
110 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
69 |
689 |
2.882e-23 |
1.219e-21 |
111 |
HOMEOSTATIC PROCESS |
99 |
1337 |
3.8e-23 |
1.593e-21 |
112 |
RESPONSE TO INORGANIC SUBSTANCE |
57 |
479 |
5.905e-23 |
2.453e-21 |
113 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
35 |
163 |
6.027e-23 |
2.482e-21 |
114 |
REGULATION OF RESPONSE TO WOUNDING |
53 |
413 |
6.234e-23 |
2.545e-21 |
115 |
REGULATION OF CELLULAR LOCALIZATION |
96 |
1277 |
6.69e-23 |
2.707e-21 |
116 |
AGING |
43 |
264 |
7.069e-23 |
2.836e-21 |
117 |
PROTEIN PHOSPHORYLATION |
81 |
944 |
7.138e-23 |
2.839e-21 |
118 |
TAXIS |
56 |
464 |
7.26e-23 |
2.863e-21 |
119 |
MORPHOGENESIS OF AN EPITHELIUM |
52 |
400 |
8.939e-23 |
3.495e-21 |
120 |
REGULATION OF CELL ACTIVATION |
57 |
484 |
9.907e-23 |
3.818e-21 |
121 |
NEUROGENESIS |
101 |
1402 |
9.93e-23 |
3.818e-21 |
122 |
REGULATION OF PROTEIN LOCALIZATION |
81 |
950 |
1.071e-22 |
4.084e-21 |
123 |
REGULATION OF GROWTH |
65 |
633 |
1.568e-22 |
5.932e-21 |
124 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
81 |
957 |
1.711e-22 |
6.421e-21 |
125 |
PHOSPHORYLATION |
93 |
1228 |
2.148e-22 |
7.996e-21 |
126 |
POSITIVE REGULATION OF CELL ADHESION |
50 |
376 |
2.257e-22 |
8.333e-21 |
127 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
63 |
609 |
5.057e-22 |
1.853e-20 |
128 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
57 |
505 |
8.087e-22 |
2.94e-20 |
129 |
REGULATION OF PROTEOLYSIS |
68 |
711 |
8.214e-22 |
2.963e-20 |
130 |
REGULATION OF IMMUNE RESPONSE |
75 |
858 |
1.157e-21 |
4.141e-20 |
131 |
GLAND DEVELOPMENT |
50 |
395 |
2.052e-21 |
7.29e-20 |
132 |
RESPONSE TO DRUG |
52 |
431 |
2.799e-21 |
9.866e-20 |
133 |
LYMPHOCYTE DIFFERENTIATION |
37 |
209 |
4.066e-21 |
1.423e-19 |
134 |
POSITIVE REGULATION OF MAPK CASCADE |
54 |
470 |
4.552e-21 |
1.581e-19 |
135 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
48 |
370 |
4.75e-21 |
1.637e-19 |
136 |
CELL CELL ADHESION |
61 |
608 |
1.155e-20 |
3.95e-19 |
137 |
TUBE DEVELOPMENT |
58 |
552 |
1.185e-20 |
4.024e-19 |
138 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
47 |
363 |
1.354e-20 |
4.566e-19 |
139 |
POSITIVE REGULATION OF KINASE ACTIVITY |
54 |
482 |
1.472e-20 |
4.928e-19 |
140 |
CELLULAR RESPONSE TO STRESS |
103 |
1565 |
2.945e-20 |
9.789e-19 |
141 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
43 |
307 |
2.981e-20 |
9.838e-19 |
142 |
SKELETAL SYSTEM DEVELOPMENT |
52 |
455 |
3.254e-20 |
1.066e-18 |
143 |
REPRODUCTION |
92 |
1297 |
3.341e-20 |
1.087e-18 |
144 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
41 |
285 |
8.548e-20 |
2.762e-18 |
145 |
INNATE IMMUNE RESPONSE |
60 |
619 |
1.355e-19 |
4.348e-18 |
146 |
RESPONSE TO OXYGEN LEVELS |
42 |
311 |
3.355e-19 |
1.069e-17 |
147 |
HEART DEVELOPMENT |
51 |
466 |
5.095e-19 |
1.613e-17 |
148 |
REGULATION OF CYTOKINE SECRETION |
30 |
149 |
5.396e-19 |
1.697e-17 |
149 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
51 |
470 |
7.381e-19 |
2.305e-17 |
150 |
EMBRYO DEVELOPMENT |
72 |
894 |
8.311e-19 |
2.578e-17 |
151 |
REGULATION OF OSSIFICATION |
32 |
178 |
1.252e-18 |
3.859e-17 |
152 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
62 |
691 |
1.525e-18 |
4.668e-17 |
153 |
REGULATION OF CELL CYCLE |
74 |
949 |
1.58e-18 |
4.805e-17 |
154 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
72 |
905 |
1.63e-18 |
4.926e-17 |
155 |
ANGIOGENESIS |
40 |
293 |
1.655e-18 |
4.967e-17 |
156 |
CELL PROLIFERATION |
61 |
672 |
1.681e-18 |
5.015e-17 |
157 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
47 |
408 |
1.696e-18 |
5.026e-17 |
158 |
POSITIVE REGULATION OF CELL ACTIVATION |
41 |
311 |
2.208e-18 |
6.501e-17 |
159 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
58 |
616 |
2.283e-18 |
6.681e-17 |
160 |
OSSIFICATION |
37 |
251 |
2.478e-18 |
7.206e-17 |
161 |
ZYMOGEN ACTIVATION |
26 |
112 |
2.918e-18 |
8.434e-17 |
162 |
RESPONSE TO MECHANICAL STIMULUS |
34 |
210 |
3.095e-18 |
8.889e-17 |
163 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
79 |
1079 |
3.815e-18 |
1.089e-16 |
164 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
114 |
1977 |
5.219e-18 |
1.481e-16 |
165 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
46 |
404 |
6.351e-18 |
1.791e-16 |
166 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
54 |
552 |
6.908e-18 |
1.936e-16 |
167 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
24 |
95 |
7.099e-18 |
1.978e-16 |
168 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
51 |
498 |
8.835e-18 |
2.447e-16 |
169 |
REGULATION OF SECRETION |
61 |
699 |
1.136e-17 |
3.127e-16 |
170 |
CHEMICAL HOMEOSTASIS |
69 |
874 |
1.383e-17 |
3.787e-16 |
171 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
39 |
296 |
1.57e-17 |
4.246e-16 |
172 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
30 |
167 |
1.566e-17 |
4.246e-16 |
173 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
56 |
602 |
1.597e-17 |
4.297e-16 |
174 |
POSITIVE REGULATION OF PROTEOLYSIS |
43 |
363 |
1.842e-17 |
4.926e-16 |
175 |
REGULATION OF NEURON DEATH |
36 |
252 |
2.041e-17 |
5.426e-16 |
176 |
RESPONSE TO METAL ION |
41 |
333 |
2.664e-17 |
7.044e-16 |
177 |
REGULATION OF MAP KINASE ACTIVITY |
40 |
319 |
3.475e-17 |
9.134e-16 |
178 |
T CELL DIFFERENTIATION |
26 |
123 |
3.509e-17 |
9.172e-16 |
179 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
33 |
213 |
3.851e-17 |
1.001e-15 |
180 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
62 |
750 |
8.224e-17 |
2.126e-15 |
181 |
REGULATION OF BODY FLUID LEVELS |
50 |
506 |
8.304e-17 |
2.135e-15 |
182 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
28 |
152 |
9.604e-17 |
2.455e-15 |
183 |
REGULATION OF HEMOPOIESIS |
39 |
314 |
1.216e-16 |
3.092e-15 |
184 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
46 |
437 |
1.369e-16 |
3.461e-15 |
185 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
50 |
514 |
1.58e-16 |
3.974e-15 |
186 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
26 |
131 |
1.81e-16 |
4.529e-15 |
187 |
RESPONSE TO OXIDATIVE STRESS |
41 |
352 |
1.94e-16 |
4.828e-15 |
188 |
RESPONSE TO ACID CHEMICAL |
39 |
319 |
2.091e-16 |
5.176e-15 |
189 |
REGULATION OF PROTEIN SECRETION |
43 |
389 |
2.387e-16 |
5.878e-15 |
190 |
POSITIVE REGULATION OF CELL CELL ADHESION |
34 |
243 |
3.104e-16 |
7.602e-15 |
191 |
REGULATION OF HOMEOSTATIC PROCESS |
46 |
447 |
3.268e-16 |
7.96e-15 |
192 |
REGENERATION |
28 |
161 |
4.576e-16 |
1.109e-14 |
193 |
REGULATION OF INFLAMMATORY RESPONSE |
37 |
294 |
4.928e-16 |
1.188e-14 |
194 |
GLIOGENESIS |
29 |
175 |
5.173e-16 |
1.241e-14 |
195 |
RESPONSE TO ESTROGEN |
32 |
218 |
5.817e-16 |
1.388e-14 |
196 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
41 |
364 |
6.336e-16 |
1.504e-14 |
197 |
PROTEIN MATURATION |
35 |
265 |
6.95e-16 |
1.642e-14 |
198 |
REGULATION OF NEURON DIFFERENTIATION |
51 |
554 |
7.517e-16 |
1.767e-14 |
199 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
59 |
724 |
9.441e-16 |
2.207e-14 |
200 |
REGULATION OF CYTOPLASMIC TRANSPORT |
47 |
481 |
1.14e-15 |
2.647e-14 |
201 |
REGULATION OF INTRACELLULAR TRANSPORT |
54 |
621 |
1.144e-15 |
2.647e-14 |
202 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
51 |
563 |
1.45e-15 |
3.34e-14 |
203 |
TUBE MORPHOGENESIS |
38 |
323 |
1.842e-15 |
4.221e-14 |
204 |
MUSCLE STRUCTURE DEVELOPMENT |
44 |
432 |
2.176e-15 |
4.963e-14 |
205 |
POSITIVE REGULATION OF CHEMOTAXIS |
24 |
120 |
2.215e-15 |
5.028e-14 |
206 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
45 |
452 |
2.398e-15 |
5.417e-14 |
207 |
RESPONSE TO PURINE CONTAINING COMPOUND |
27 |
158 |
2.434e-15 |
5.47e-14 |
208 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
46 |
472 |
2.578e-15 |
5.768e-14 |
209 |
EPITHELIAL CELL DIFFERENTIATION |
47 |
495 |
3.417e-15 |
7.608e-14 |
210 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
56 |
684 |
4.441e-15 |
9.841e-14 |
211 |
CELL CHEMOTAXIS |
27 |
162 |
4.637e-15 |
1.018e-13 |
212 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
27 |
162 |
4.637e-15 |
1.018e-13 |
213 |
REGULATION OF LEUKOCYTE MIGRATION |
26 |
149 |
4.786e-15 |
1.045e-13 |
214 |
RESPONSE TO CORTICOSTEROID |
28 |
176 |
4.912e-15 |
1.068e-13 |
215 |
REGULATION OF NEURON APOPTOTIC PROCESS |
29 |
192 |
6.472e-15 |
1.401e-13 |
216 |
REGULATION OF CHEMOTAXIS |
28 |
180 |
8.865e-15 |
1.91e-13 |
217 |
REGULATION OF INNATE IMMUNE RESPONSE |
39 |
357 |
9.229e-15 |
1.979e-13 |
218 |
CELLULAR HOMEOSTASIS |
55 |
676 |
1.036e-14 |
2.212e-13 |
219 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
30 |
211 |
1.164e-14 |
2.474e-13 |
220 |
RESPONSE TO KETONE |
28 |
182 |
1.184e-14 |
2.503e-13 |
221 |
CELL FATE COMMITMENT |
31 |
227 |
1.295e-14 |
2.728e-13 |
222 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
47 |
513 |
1.319e-14 |
2.765e-13 |
223 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
52 |
616 |
1.341e-14 |
2.797e-13 |
224 |
PEPTIDYL AMINO ACID MODIFICATION |
62 |
841 |
1.724e-14 |
3.581e-13 |
225 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
39 |
365 |
1.915e-14 |
3.961e-13 |
226 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
29 |
200 |
1.931e-14 |
3.976e-13 |
227 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
48 |
541 |
2.305e-14 |
4.705e-13 |
228 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
48 |
541 |
2.305e-14 |
4.705e-13 |
229 |
RESPONSE TO PEPTIDE |
41 |
404 |
2.319e-14 |
4.713e-13 |
230 |
GLAND MORPHOGENESIS |
21 |
97 |
2.386e-14 |
4.826e-13 |
231 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
33 |
264 |
2.411e-14 |
4.857e-13 |
232 |
RHYTHMIC PROCESS |
35 |
298 |
2.598e-14 |
5.211e-13 |
233 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
22 |
109 |
2.697e-14 |
5.385e-13 |
234 |
REGULATION OF BINDING |
34 |
283 |
3.148e-14 |
6.26e-13 |
235 |
CELLULAR RESPONSE TO ACID CHEMICAL |
27 |
175 |
3.307e-14 |
6.548e-13 |
236 |
MESENCHYME DEVELOPMENT |
28 |
190 |
3.618e-14 |
7.133e-13 |
237 |
REGULATION OF CELL MORPHOGENESIS |
48 |
552 |
4.929e-14 |
9.677e-13 |
238 |
REGULATION OF ORGANELLE ORGANIZATION |
75 |
1178 |
5.22e-14 |
1.02e-12 |
239 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
48 |
554 |
5.647e-14 |
1.099e-12 |
240 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
24 |
138 |
5.897e-14 |
1.143e-12 |
241 |
CONNECTIVE TISSUE DEVELOPMENT |
28 |
194 |
6.187e-14 |
1.195e-12 |
242 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
25 |
153 |
7.76e-14 |
1.492e-12 |
243 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
41 |
422 |
1.007e-13 |
1.928e-12 |
244 |
MULTI MULTICELLULAR ORGANISM PROCESS |
29 |
213 |
1.019e-13 |
1.944e-12 |
245 |
CELLULAR COMPONENT MORPHOGENESIS |
63 |
900 |
1.099e-13 |
2.088e-12 |
246 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
23 |
129 |
1.142e-13 |
2.16e-12 |
247 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
33 |
279 |
1.189e-13 |
2.24e-12 |
248 |
LEUKOCYTE CHEMOTAXIS |
22 |
117 |
1.258e-13 |
2.36e-12 |
249 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
26 |
171 |
1.417e-13 |
2.648e-12 |
250 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
38 |
370 |
1.475e-13 |
2.745e-12 |
251 |
REGULATION OF SYSTEM PROCESS |
45 |
507 |
1.546e-13 |
2.866e-12 |
252 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
24 |
144 |
1.567e-13 |
2.893e-12 |
253 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
33 |
282 |
1.614e-13 |
2.969e-12 |
254 |
REGULATION OF VASCULATURE DEVELOPMENT |
30 |
233 |
1.702e-13 |
3.119e-12 |
255 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
29 |
218 |
1.868e-13 |
3.408e-12 |
256 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
47 |
552 |
1.989e-13 |
3.616e-12 |
257 |
NEGATIVE REGULATION OF CELL CYCLE |
41 |
433 |
2.369e-13 |
4.29e-12 |
258 |
REGULATION OF LEUKOCYTE PROLIFERATION |
28 |
206 |
2.855e-13 |
5.148e-12 |
259 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
25 |
162 |
2.973e-13 |
5.341e-12 |
260 |
POSITIVE REGULATION OF GROWTH |
30 |
238 |
2.994e-13 |
5.359e-12 |
261 |
REGULATION OF DEVELOPMENTAL GROWTH |
33 |
289 |
3.242e-13 |
5.757e-12 |
262 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
33 |
289 |
3.242e-13 |
5.757e-12 |
263 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
20 |
98 |
3.265e-13 |
5.777e-12 |
264 |
EMBRYONIC MORPHOGENESIS |
46 |
539 |
3.356e-13 |
5.914e-12 |
265 |
POSITIVE REGULATION OF HEMOPOIESIS |
25 |
163 |
3.431e-13 |
6.025e-12 |
266 |
MUSCLE TISSUE DEVELOPMENT |
32 |
275 |
4.443e-13 |
7.771e-12 |
267 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
20 |
100 |
4.885e-13 |
8.513e-12 |
268 |
POSITIVE REGULATION OF PROTEIN SECRETION |
28 |
211 |
5.222e-13 |
9.066e-12 |
269 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
24 |
152 |
5.339e-13 |
9.236e-12 |
270 |
PROTEOLYSIS |
74 |
1208 |
5.419e-13 |
9.339e-12 |
271 |
REGULATION OF PROTEIN IMPORT |
26 |
183 |
7.194e-13 |
1.235e-11 |
272 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
21 |
115 |
8.308e-13 |
1.421e-11 |
273 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
20 |
103 |
8.775e-13 |
1.496e-11 |
274 |
SENSORY ORGAN DEVELOPMENT |
43 |
493 |
9.961e-13 |
1.692e-11 |
275 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
35 |
337 |
1.007e-12 |
1.704e-11 |
276 |
RESPONSE TO RADIATION |
39 |
413 |
1.016e-12 |
1.712e-11 |
277 |
NEURON DIFFERENTIATION |
60 |
874 |
1.034e-12 |
1.737e-11 |
278 |
NEGATIVE REGULATION OF NEURON DEATH |
25 |
171 |
1.04e-12 |
1.741e-11 |
279 |
POSITIVE REGULATION OF PROTEIN IMPORT |
20 |
104 |
1.062e-12 |
1.771e-11 |
280 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
58 |
829 |
1.176e-12 |
1.955e-11 |
281 |
REGULATION OF FAT CELL DIFFERENTIATION |
20 |
106 |
1.544e-12 |
2.556e-11 |
282 |
STEM CELL DIFFERENTIATION |
26 |
190 |
1.746e-12 |
2.881e-11 |
283 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
55 |
767 |
1.803e-12 |
2.965e-11 |
284 |
NEGATIVE REGULATION OF CELL ADHESION |
28 |
223 |
2.071e-12 |
3.392e-11 |
285 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
19 |
96 |
2.29e-12 |
3.739e-11 |
286 |
REGULATION OF PROTEIN KINASE B SIGNALING |
21 |
121 |
2.333e-12 |
3.795e-11 |
287 |
IMMUNE EFFECTOR PROCESS |
42 |
486 |
2.51e-12 |
4.069e-11 |
288 |
IN UTERO EMBRYONIC DEVELOPMENT |
33 |
311 |
2.529e-12 |
4.071e-11 |
289 |
HEMOSTASIS |
33 |
311 |
2.529e-12 |
4.071e-11 |
290 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
59 |
872 |
2.975e-12 |
4.774e-11 |
291 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
18 |
86 |
3.192e-12 |
5.104e-11 |
292 |
DEVELOPMENTAL GROWTH |
34 |
333 |
3.472e-12 |
5.533e-11 |
293 |
GROWTH |
38 |
410 |
3.551e-12 |
5.639e-11 |
294 |
HEART MORPHOGENESIS |
27 |
212 |
3.678e-12 |
5.822e-11 |
295 |
COLLAGEN FIBRIL ORGANIZATION |
13 |
38 |
3.716e-12 |
5.861e-11 |
296 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
84 |
1527 |
3.832e-12 |
6.024e-11 |
297 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
30 |
263 |
4.069e-12 |
6.374e-11 |
298 |
PLACENTA DEVELOPMENT |
22 |
138 |
4.113e-12 |
6.422e-11 |
299 |
RESPONSE TO ORGANOPHOSPHORUS |
22 |
139 |
4.775e-12 |
7.431e-11 |
300 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
28 |
232 |
5.473e-12 |
8.488e-11 |
301 |
REGULATION OF DNA METABOLIC PROCESS |
34 |
340 |
6.223e-12 |
9.62e-11 |
302 |
RESPONSE TO EXTRACELLULAR STIMULUS |
39 |
441 |
7.788e-12 |
1.2e-10 |
303 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
19 |
103 |
8.528e-12 |
1.31e-10 |
304 |
REGULATION OF PROTEIN TARGETING |
32 |
307 |
8.821e-12 |
1.35e-10 |
305 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
27 |
220 |
8.88e-12 |
1.355e-10 |
306 |
CELLULAR CHEMICAL HOMEOSTASIS |
45 |
570 |
8.959e-12 |
1.362e-10 |
307 |
MUSCLE CELL DIFFERENTIATION |
28 |
237 |
9.197e-12 |
1.394e-10 |
308 |
MYELOID CELL DIFFERENTIATION |
25 |
189 |
1.008e-11 |
1.522e-10 |
309 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
26 |
207 |
1.277e-11 |
1.923e-10 |
310 |
FAT CELL DIFFERENTIATION |
19 |
106 |
1.449e-11 |
2.174e-10 |
311 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
23 |
162 |
1.572e-11 |
2.352e-10 |
312 |
MESENCHYMAL CELL DIFFERENTIATION |
21 |
134 |
1.781e-11 |
2.656e-10 |
313 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
20 |
121 |
1.984e-11 |
2.949e-10 |
314 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
21 |
135 |
2.061e-11 |
3.044e-10 |
315 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
27 |
228 |
2.058e-11 |
3.044e-10 |
316 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
58 |
891 |
2.188e-11 |
3.222e-10 |
317 |
MYELOID LEUKOCYTE DIFFERENTIATION |
18 |
96 |
2.274e-11 |
3.321e-10 |
318 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
18 |
96 |
2.274e-11 |
3.321e-10 |
319 |
POSITIVE REGULATION OF OSSIFICATION |
17 |
84 |
2.277e-11 |
3.321e-10 |
320 |
GLIAL CELL DIFFERENTIATION |
21 |
136 |
2.381e-11 |
3.463e-10 |
321 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
34 |
360 |
3.024e-11 |
4.384e-10 |
322 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
24 |
183 |
3.157e-11 |
4.562e-10 |
323 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
35 |
381 |
3.339e-11 |
4.811e-10 |
324 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
48 |
662 |
3.524e-11 |
5.045e-10 |
325 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
48 |
662 |
3.524e-11 |
5.045e-10 |
326 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
24 |
184 |
3.548e-11 |
5.064e-10 |
327 |
HEAD DEVELOPMENT |
50 |
709 |
3.616e-11 |
5.145e-10 |
328 |
AMEBOIDAL TYPE CELL MIGRATION |
22 |
154 |
3.855e-11 |
5.469e-10 |
329 |
REGULATION OF METAL ION TRANSPORT |
32 |
325 |
3.971e-11 |
5.599e-10 |
330 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
19 |
112 |
3.961e-11 |
5.599e-10 |
331 |
TISSUE REMODELING |
17 |
87 |
4.115e-11 |
5.785e-10 |
332 |
APOPTOTIC SIGNALING PATHWAY |
30 |
289 |
4.437e-11 |
6.219e-10 |
333 |
REGULATION OF STEM CELL DIFFERENTIATION |
19 |
113 |
4.653e-11 |
6.502e-10 |
334 |
REGULATION OF CHEMOKINE PRODUCTION |
15 |
65 |
4.704e-11 |
6.534e-10 |
335 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
15 |
65 |
4.704e-11 |
6.534e-10 |
336 |
EMBRYONIC ORGAN DEVELOPMENT |
36 |
406 |
4.749e-11 |
6.577e-10 |
337 |
POSITIVE REGULATION OF BINDING |
20 |
127 |
4.942e-11 |
6.823e-10 |
338 |
NEGATIVE REGULATION OF PROTEOLYSIS |
32 |
329 |
5.464e-11 |
7.522e-10 |
339 |
REGULATION OF ERK1 AND ERK2 CASCADE |
27 |
238 |
5.586e-11 |
7.667e-10 |
340 |
POSITIVE REGULATION OF SECRETION |
34 |
370 |
6.378e-11 |
8.729e-10 |
341 |
REGULATION OF CELL GROWTH |
35 |
391 |
6.855e-11 |
9.353e-10 |
342 |
RESPONSE TO INTERFERON GAMMA |
21 |
144 |
7.235e-11 |
9.815e-10 |
343 |
REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
21 |
144 |
7.235e-11 |
9.815e-10 |
344 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
34 |
372 |
7.38e-11 |
9.983e-10 |
345 |
HOMEOSTASIS OF NUMBER OF CELLS |
23 |
175 |
7.813e-11 |
1.054e-09 |
346 |
REGULATION OF ORGAN MORPHOGENESIS |
27 |
242 |
8.202e-11 |
1.103e-09 |
347 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
19 |
118 |
1.015e-10 |
1.361e-09 |
348 |
UROGENITAL SYSTEM DEVELOPMENT |
30 |
299 |
1.032e-10 |
1.38e-09 |
349 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
16 |
80 |
1.07e-10 |
1.426e-09 |
350 |
CARTILAGE DEVELOPMENT |
21 |
147 |
1.076e-10 |
1.43e-09 |
351 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
27 |
246 |
1.194e-10 |
1.583e-09 |
352 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
16 |
81 |
1.303e-10 |
1.717e-09 |
353 |
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
16 |
81 |
1.303e-10 |
1.717e-09 |
354 |
CYTOKINE PRODUCTION |
19 |
120 |
1.37e-10 |
1.801e-09 |
355 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
24 |
197 |
1.507e-10 |
1.97e-09 |
356 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
24 |
197 |
1.507e-10 |
1.97e-09 |
357 |
ENDOCYTOSIS |
40 |
509 |
1.558e-10 |
2.031e-09 |
358 |
LEUKOCYTE HOMEOSTASIS |
14 |
60 |
1.786e-10 |
2.321e-09 |
359 |
RESPONSE TO PROGESTERONE |
13 |
50 |
1.854e-10 |
2.403e-09 |
360 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
25 |
216 |
1.89e-10 |
2.443e-09 |
361 |
EYE DEVELOPMENT |
31 |
326 |
1.939e-10 |
2.499e-09 |
362 |
ACTIVATION OF IMMUNE RESPONSE |
36 |
427 |
1.952e-10 |
2.502e-09 |
363 |
MULTICELLULAR ORGANISM REPRODUCTION |
51 |
768 |
1.951e-10 |
2.502e-09 |
364 |
CARDIOCYTE DIFFERENTIATION |
17 |
96 |
2.109e-10 |
2.696e-09 |
365 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
20 |
138 |
2.306e-10 |
2.932e-09 |
366 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
25 |
218 |
2.305e-10 |
2.932e-09 |
367 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
23 |
185 |
2.426e-10 |
3.075e-09 |
368 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
26 |
236 |
2.438e-10 |
3.083e-09 |
369 |
REGULATION OF WNT SIGNALING PATHWAY |
30 |
310 |
2.501e-10 |
3.154e-09 |
370 |
CELL CYCLE ARREST |
21 |
154 |
2.613e-10 |
3.286e-09 |
371 |
PEPTIDYL TYROSINE MODIFICATION |
23 |
186 |
2.705e-10 |
3.392e-09 |
372 |
POSITIVE REGULATION OF CELL CYCLE |
31 |
332 |
3.055e-10 |
3.821e-09 |
373 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
24 |
204 |
3.124e-10 |
3.897e-09 |
374 |
MUSCLE ORGAN DEVELOPMENT |
28 |
277 |
3.693e-10 |
4.588e-09 |
375 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
36 |
437 |
3.697e-10 |
4.588e-09 |
376 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
33 |
375 |
3.795e-10 |
4.696e-09 |
377 |
PLATELET ACTIVATION |
20 |
142 |
3.888e-10 |
4.799e-09 |
378 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
24 |
207 |
4.228e-10 |
5.204e-09 |
379 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
23 |
191 |
4.612e-10 |
5.662e-09 |
380 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
16 |
88 |
4.783e-10 |
5.841e-09 |
381 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
16 |
88 |
4.783e-10 |
5.841e-09 |
382 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
17 |
101 |
4.824e-10 |
5.876e-09 |
383 |
EXTRACELLULAR MATRIX DISASSEMBLY |
15 |
76 |
5.012e-10 |
6.088e-09 |
384 |
REGULATION OF CALCIUM ION TRANSPORT |
24 |
209 |
5.156e-10 |
6.247e-09 |
385 |
REGULATION OF LIPID METABOLIC PROCESS |
28 |
282 |
5.572e-10 |
6.735e-09 |
386 |
RESPONSE TO IONIZING RADIATION |
20 |
145 |
5.683e-10 |
6.833e-09 |
387 |
NEGATIVE REGULATION OF MAPK CASCADE |
20 |
145 |
5.683e-10 |
6.833e-09 |
388 |
SKIN DEVELOPMENT |
24 |
211 |
6.272e-10 |
7.522e-09 |
389 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
19 |
131 |
6.432e-10 |
7.694e-09 |
390 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
25 |
229 |
6.575e-10 |
7.844e-09 |
391 |
MAMMARY GLAND DEVELOPMENT |
18 |
117 |
6.818e-10 |
8.114e-09 |
392 |
REGULATION OF CELL PROJECTION ORGANIZATION |
41 |
558 |
6.927e-10 |
8.223e-09 |
393 |
REGULATION OF T CELL PROLIFERATION |
20 |
147 |
7.279e-10 |
8.619e-09 |
394 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
34 |
406 |
7.544e-10 |
8.91e-09 |
395 |
RESPONSE TO CAMP |
17 |
104 |
7.737e-10 |
9.114e-09 |
396 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
29 |
306 |
8.175e-10 |
9.605e-09 |
397 |
POSITIVE REGULATION OF CELL GROWTH |
20 |
148 |
8.225e-10 |
9.616e-09 |
398 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
20 |
148 |
8.225e-10 |
9.616e-09 |
399 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
37 |
472 |
8.357e-10 |
9.745e-09 |
400 |
CELL AGING |
14 |
67 |
8.589e-10 |
9.991e-09 |
401 |
ADAPTIVE IMMUNE RESPONSE |
28 |
288 |
9.014e-10 |
1.046e-08 |
402 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
14 |
68 |
1.057e-09 |
1.224e-08 |
403 |
REGULATION OF ION TRANSPORT |
42 |
592 |
1.224e-09 |
1.413e-08 |
404 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
19 |
136 |
1.232e-09 |
1.419e-08 |
405 |
REGULATION OF CYTOSKELETON ORGANIZATION |
38 |
502 |
1.31e-09 |
1.505e-08 |
406 |
NEGATIVE REGULATION OF TRANSPORT |
36 |
458 |
1.325e-09 |
1.514e-08 |
407 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
16 |
94 |
1.322e-09 |
1.514e-08 |
408 |
REGULATION OF PROTEIN BINDING |
21 |
168 |
1.332e-09 |
1.516e-08 |
409 |
RESPONSE TO CARBOHYDRATE |
21 |
168 |
1.332e-09 |
1.516e-08 |
410 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
11 |
38 |
1.34e-09 |
1.52e-08 |
411 |
CELLULAR RESPONSE TO INTERFERON GAMMA |
18 |
122 |
1.37e-09 |
1.551e-08 |
412 |
ENDOCRINE SYSTEM DEVELOPMENT |
18 |
123 |
1.569e-09 |
1.772e-08 |
413 |
PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
17 |
109 |
1.639e-09 |
1.847e-08 |
414 |
ORGAN REGENERATION |
15 |
83 |
1.829e-09 |
2.056e-08 |
415 |
FORMATION OF PRIMARY GERM LAYER |
17 |
110 |
1.895e-09 |
2.124e-08 |
416 |
CELL CYCLE PROCESS |
61 |
1081 |
1.919e-09 |
2.146e-08 |
417 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
12 |
49 |
1.989e-09 |
2.22e-08 |
418 |
BONE DEVELOPMENT |
20 |
156 |
2.108e-09 |
2.34e-08 |
419 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
20 |
156 |
2.108e-09 |
2.34e-08 |
420 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
13 |
60 |
2.151e-09 |
2.377e-08 |
421 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
13 |
60 |
2.151e-09 |
2.377e-08 |
422 |
REGULATION OF WOUND HEALING |
18 |
126 |
2.335e-09 |
2.574e-08 |
423 |
REGULATION OF MITOTIC CELL CYCLE |
36 |
468 |
2.362e-09 |
2.598e-08 |
424 |
RESPONSE TO VITAMIN |
16 |
98 |
2.491e-09 |
2.733e-08 |
425 |
RESPONSE TO AMINO ACID |
17 |
112 |
2.52e-09 |
2.758e-08 |
426 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
12 |
50 |
2.559e-09 |
2.795e-08 |
427 |
RESPONSE TO NUTRIENT |
22 |
191 |
2.576e-09 |
2.807e-08 |
428 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
28 |
303 |
2.832e-09 |
3.058e-08 |
429 |
POSITIVE REGULATION OF STAT CASCADE |
14 |
73 |
2.83e-09 |
3.058e-08 |
430 |
POSITIVE REGULATION OF JAK STAT CASCADE |
14 |
73 |
2.83e-09 |
3.058e-08 |
431 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
28 |
303 |
2.832e-09 |
3.058e-08 |
432 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
16 |
99 |
2.904e-09 |
3.12e-08 |
433 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
17 |
113 |
2.898e-09 |
3.12e-08 |
434 |
RESPONSE TO VIRUS |
25 |
247 |
3.189e-09 |
3.419e-08 |
435 |
CELL CYCLE |
69 |
1316 |
3.224e-09 |
3.448e-08 |
436 |
CIRCULATORY SYSTEM PROCESS |
31 |
366 |
3.29e-09 |
3.511e-08 |
437 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
15 |
87 |
3.612e-09 |
3.794e-08 |
438 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
15 |
87 |
3.612e-09 |
3.794e-08 |
439 |
VIRAL ENTRY INTO HOST CELL |
15 |
87 |
3.612e-09 |
3.794e-08 |
440 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
15 |
87 |
3.612e-09 |
3.794e-08 |
441 |
MOVEMENT IN HOST ENVIRONMENT |
15 |
87 |
3.612e-09 |
3.794e-08 |
442 |
ENTRY INTO HOST |
15 |
87 |
3.612e-09 |
3.794e-08 |
443 |
ENTRY INTO HOST CELL |
15 |
87 |
3.612e-09 |
3.794e-08 |
444 |
RESPONSE TO INTERLEUKIN 1 |
17 |
115 |
3.818e-09 |
3.984e-08 |
445 |
CELLULAR RESPONSE TO ALCOHOL |
17 |
115 |
3.818e-09 |
3.984e-08 |
446 |
REGULATION OF MUSCLE SYSTEM PROCESS |
22 |
195 |
3.808e-09 |
3.984e-08 |
447 |
REGULATION OF VITAMIN METABOLIC PROCESS |
7 |
12 |
4.046e-09 |
4.212e-08 |
448 |
REGULATION OF CARTILAGE DEVELOPMENT |
13 |
63 |
4.07e-09 |
4.228e-08 |
449 |
RESPONSE TO ESTRADIOL |
19 |
146 |
4.142e-09 |
4.292e-08 |
450 |
POSITIVE REGULATION OF DNA BINDING |
11 |
42 |
4.356e-09 |
4.504e-08 |
451 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
16 |
102 |
4.549e-09 |
4.693e-08 |
452 |
CELL CELL SIGNALING |
48 |
767 |
4.77e-09 |
4.91e-08 |
453 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
12 |
53 |
5.255e-09 |
5.398e-08 |
454 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
46 |
720 |
5.391e-09 |
5.525e-08 |
455 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
22 |
199 |
5.569e-09 |
5.695e-08 |
456 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
26 |
274 |
6.043e-09 |
6.166e-08 |
457 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
32 |
397 |
6.123e-09 |
6.234e-08 |
458 |
REGULATION OF ION HOMEOSTASIS |
22 |
201 |
6.71e-09 |
6.817e-08 |
459 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
15 |
92 |
8.021e-09 |
8.131e-08 |
460 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
14 |
79 |
8.308e-09 |
8.386e-08 |
461 |
BONE MORPHOGENESIS |
14 |
79 |
8.308e-09 |
8.386e-08 |
462 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
17 |
121 |
8.429e-09 |
8.489e-08 |
463 |
CELLULAR COMPONENT DISASSEMBLY |
37 |
515 |
8.849e-09 |
8.893e-08 |
464 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
13 |
67 |
9.009e-09 |
9.034e-08 |
465 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
15 |
93 |
9.348e-09 |
9.354e-08 |
466 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
17 |
122 |
9.572e-09 |
9.557e-08 |
467 |
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
11 |
45 |
9.654e-09 |
9.619e-08 |
468 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
14 |
80 |
9.844e-09 |
9.787e-08 |
469 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
19 |
154 |
1.015e-08 |
1.007e-07 |
470 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
32 |
408 |
1.18e-08 |
1.169e-07 |
471 |
RESPONSE TO HYDROGEN PEROXIDE |
16 |
109 |
1.219e-08 |
1.204e-07 |
472 |
INOSITOL LIPID MEDIATED SIGNALING |
17 |
124 |
1.229e-08 |
1.212e-07 |
473 |
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY |
24 |
245 |
1.256e-08 |
1.235e-07 |
474 |
STRIATED MUSCLE CELL DIFFERENTIATION |
20 |
173 |
1.285e-08 |
1.261e-07 |
475 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
39 |
573 |
1.533e-08 |
1.502e-07 |
476 |
NEGATIVE REGULATION OF CELL ACTIVATION |
19 |
158 |
1.554e-08 |
1.519e-07 |
477 |
REGULATION OF INTERLEUKIN 1 PRODUCTION |
12 |
58 |
1.569e-08 |
1.53e-07 |
478 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
13 |
70 |
1.575e-08 |
1.533e-07 |
479 |
DEFENSE RESPONSE TO OTHER ORGANISM |
36 |
505 |
1.729e-08 |
1.679e-07 |
480 |
ION HOMEOSTASIS |
39 |
576 |
1.767e-08 |
1.713e-07 |
481 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
11 |
48 |
2.009e-08 |
1.943e-07 |
482 |
REGULATION OF JAK STAT CASCADE |
18 |
144 |
2.018e-08 |
1.944e-07 |
483 |
REGULATION OF STAT CASCADE |
18 |
144 |
2.018e-08 |
1.944e-07 |
484 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
23 |
233 |
2.191e-08 |
2.107e-07 |
485 |
REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
18 |
145 |
2.252e-08 |
2.16e-07 |
486 |
CHONDROCYTE DIFFERENTIATION |
12 |
60 |
2.353e-08 |
2.253e-07 |
487 |
REGULATION OF CATABOLIC PROCESS |
45 |
731 |
2.429e-08 |
2.32e-07 |
488 |
CELLULAR RESPONSE TO PEPTIDE |
25 |
274 |
2.601e-08 |
2.48e-07 |
489 |
REGULATION OF ORGAN GROWTH |
13 |
73 |
2.674e-08 |
2.544e-07 |
490 |
NEGATIVE REGULATION OF GROWTH |
23 |
236 |
2.785e-08 |
2.645e-07 |
491 |
CYTOSKELETON ORGANIZATION |
49 |
838 |
2.854e-08 |
2.704e-07 |
492 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
32 |
424 |
2.933e-08 |
2.774e-07 |
493 |
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
15 |
101 |
2.966e-08 |
2.8e-07 |
494 |
LYMPHOCYTE HOMEOSTASIS |
11 |
50 |
3.175e-08 |
2.984e-07 |
495 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
13 |
74 |
3.171e-08 |
2.984e-07 |
496 |
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY |
17 |
132 |
3.187e-08 |
2.984e-07 |
497 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
17 |
132 |
3.187e-08 |
2.984e-07 |
498 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
15 |
102 |
3.399e-08 |
3.176e-07 |
499 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
24 |
258 |
3.42e-08 |
3.189e-07 |
500 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
12 |
62 |
3.472e-08 |
3.231e-07 |
501 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
13 |
75 |
3.749e-08 |
3.482e-07 |
502 |
SYSTEM PROCESS |
82 |
1785 |
3.811e-08 |
3.532e-07 |
503 |
NEURON PROJECTION DEVELOPMENT |
37 |
545 |
3.881e-08 |
3.59e-07 |
504 |
REGULATION OF INTERLEUKIN 12 PRODUCTION |
11 |
51 |
3.958e-08 |
3.654e-07 |
505 |
INTERACTION WITH HOST |
17 |
134 |
3.997e-08 |
3.677e-07 |
506 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
21 |
203 |
3.999e-08 |
3.677e-07 |
507 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
28 |
343 |
4.229e-08 |
3.882e-07 |
508 |
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY |
9 |
31 |
4.239e-08 |
3.882e-07 |
509 |
CELL PROJECTION ORGANIZATION |
51 |
902 |
4.292e-08 |
3.924e-07 |
510 |
EPITHELIAL CELL DEVELOPMENT |
20 |
186 |
4.41e-08 |
4.023e-07 |
511 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
15 |
104 |
4.442e-08 |
4.045e-07 |
512 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
10 |
41 |
4.695e-08 |
4.262e-07 |
513 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
14 |
90 |
4.699e-08 |
4.262e-07 |
514 |
TISSUE REGENERATION |
11 |
52 |
4.909e-08 |
4.435e-07 |
515 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
11 |
52 |
4.909e-08 |
4.435e-07 |
516 |
RESPONSE TO ETHANOL |
17 |
136 |
4.993e-08 |
4.502e-07 |
517 |
GLUCOSE HOMEOSTASIS |
19 |
170 |
5.148e-08 |
4.624e-07 |
518 |
CARBOHYDRATE HOMEOSTASIS |
19 |
170 |
5.148e-08 |
4.624e-07 |
519 |
CIRCADIAN RHYTHM |
17 |
137 |
5.571e-08 |
4.995e-07 |
520 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
15 |
106 |
5.768e-08 |
5.161e-07 |
521 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
11 |
53 |
6.057e-08 |
5.399e-07 |
522 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
11 |
53 |
6.057e-08 |
5.399e-07 |
523 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
19 |
172 |
6.218e-08 |
5.532e-07 |
524 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
20 |
190 |
6.3e-08 |
5.594e-07 |
525 |
TELENCEPHALON DEVELOPMENT |
22 |
228 |
6.674e-08 |
5.915e-07 |
526 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
17 |
139 |
6.915e-08 |
6.117e-07 |
527 |
REGULATION OF DNA BINDING |
14 |
93 |
7.203e-08 |
6.359e-07 |
528 |
ALPHA BETA T CELL ACTIVATION |
11 |
54 |
7.437e-08 |
6.554e-07 |
529 |
POSITIVE REGULATION OF NEURON DEATH |
12 |
67 |
8.61e-08 |
7.573e-07 |
530 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
11 |
55 |
9.09e-08 |
7.952e-07 |
531 |
REGULATION OF KIDNEY DEVELOPMENT |
11 |
55 |
9.09e-08 |
7.952e-07 |
532 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
22 |
232 |
9.092e-08 |
7.952e-07 |
533 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
14 |
95 |
9.485e-08 |
8.28e-07 |
534 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
13 |
81 |
9.704e-08 |
8.455e-07 |
535 |
RESPONSE TO TUMOR NECROSIS FACTOR |
22 |
233 |
9.812e-08 |
8.533e-07 |
536 |
EPIDERMIS DEVELOPMENT |
23 |
253 |
1.007e-07 |
8.74e-07 |
537 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
34 |
1.032e-07 |
8.941e-07 |
538 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
11 |
56 |
1.106e-07 |
9.548e-07 |
539 |
OUTFLOW TRACT MORPHOGENESIS |
11 |
56 |
1.106e-07 |
9.548e-07 |
540 |
RESPIRATORY SYSTEM DEVELOPMENT |
20 |
197 |
1.149e-07 |
9.882e-07 |
541 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
20 |
197 |
1.149e-07 |
9.882e-07 |
542 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
19 |
179 |
1.178e-07 |
1.011e-06 |
543 |
NEGATIVE REGULATION OF OSSIFICATION |
12 |
69 |
1.21e-07 |
1.037e-06 |
544 |
ALPHA BETA T CELL DIFFERENTIATION |
10 |
45 |
1.222e-07 |
1.045e-06 |
545 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
16 |
128 |
1.235e-07 |
1.055e-06 |
546 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
18 |
162 |
1.265e-07 |
1.078e-06 |
547 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
17 |
145 |
1.292e-07 |
1.099e-06 |
548 |
DEFENSE RESPONSE TO BACTERIUM |
22 |
237 |
1.325e-07 |
1.125e-06 |
549 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
11 |
57 |
1.34e-07 |
1.134e-06 |
550 |
ENDOTHELIAL CELL MIGRATION |
11 |
57 |
1.34e-07 |
1.134e-06 |
551 |
REGULATION OF ENDOCYTOSIS |
20 |
199 |
1.357e-07 |
1.146e-06 |
552 |
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE |
14 |
98 |
1.414e-07 |
1.192e-06 |
553 |
TISSUE MIGRATION |
13 |
84 |
1.511e-07 |
1.272e-06 |
554 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
10 |
46 |
1.527e-07 |
1.28e-06 |
555 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
10 |
46 |
1.527e-07 |
1.28e-06 |
556 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
29 |
387 |
1.536e-07 |
1.285e-06 |
557 |
SKELETAL SYSTEM MORPHOGENESIS |
20 |
201 |
1.599e-07 |
1.336e-06 |
558 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
11 |
58 |
1.617e-07 |
1.346e-06 |
559 |
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS |
11 |
58 |
1.617e-07 |
1.346e-06 |
560 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
13 |
85 |
1.744e-07 |
1.447e-06 |
561 |
TOLL LIKE RECEPTOR SIGNALING PATHWAY |
13 |
85 |
1.744e-07 |
1.447e-06 |
562 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
9 |
36 |
1.772e-07 |
1.464e-06 |
563 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
9 |
36 |
1.772e-07 |
1.464e-06 |
564 |
THYMUS DEVELOPMENT |
10 |
47 |
1.897e-07 |
1.562e-06 |
565 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
23 |
262 |
1.896e-07 |
1.562e-06 |
566 |
MAINTENANCE OF CELL NUMBER |
16 |
132 |
1.903e-07 |
1.564e-06 |
567 |
POSITIVE REGULATION OF DNA REPLICATION |
13 |
86 |
2.009e-07 |
1.649e-06 |
568 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
16 |
133 |
2.114e-07 |
1.732e-06 |
569 |
NEURON PROJECTION GUIDANCE |
20 |
205 |
2.206e-07 |
1.804e-06 |
570 |
GLIAL CELL MIGRATION |
9 |
37 |
2.29e-07 |
1.869e-06 |
571 |
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE |
12 |
73 |
2.305e-07 |
1.875e-06 |
572 |
ACUTE INFLAMMATORY RESPONSE |
12 |
73 |
2.305e-07 |
1.875e-06 |
573 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
10 |
48 |
2.343e-07 |
1.903e-06 |
574 |
NEURON DEVELOPMENT |
41 |
687 |
2.4e-07 |
1.945e-06 |
575 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
19 |
188 |
2.556e-07 |
2.069e-06 |
576 |
REGULATION OF COAGULATION |
13 |
88 |
2.649e-07 |
2.136e-06 |
577 |
REGULATION OF STEM CELL PROLIFERATION |
13 |
88 |
2.649e-07 |
2.136e-06 |
578 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
14 |
103 |
2.662e-07 |
2.143e-06 |
579 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
12 |
74 |
2.69e-07 |
2.158e-06 |
580 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
12 |
74 |
2.69e-07 |
2.158e-06 |
581 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
11 |
61 |
2.776e-07 |
2.219e-06 |
582 |
REGULATION OF INTERLEUKIN 8 PRODUCTION |
11 |
61 |
2.776e-07 |
2.219e-06 |
583 |
PALLIUM DEVELOPMENT |
17 |
153 |
2.827e-07 |
2.256e-06 |
584 |
REGULATION OF STEROID BIOSYNTHETIC PROCESS |
10 |
49 |
2.879e-07 |
2.294e-06 |
585 |
CARDIAC CHAMBER MORPHOGENESIS |
14 |
104 |
3.007e-07 |
2.388e-06 |
586 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
14 |
104 |
3.007e-07 |
2.388e-06 |
587 |
ARTERY DEVELOPMENT |
12 |
75 |
3.131e-07 |
2.478e-06 |
588 |
NEURAL CREST CELL DIFFERENTIATION |
12 |
75 |
3.131e-07 |
2.478e-06 |
589 |
PARTURITION |
7 |
20 |
3.33e-07 |
2.626e-06 |
590 |
REGULATION OF MONOCYTE CHEMOTAXIS |
7 |
20 |
3.33e-07 |
2.626e-06 |
591 |
ODONTOGENESIS |
14 |
105 |
3.392e-07 |
2.671e-06 |
592 |
GASTRULATION |
17 |
155 |
3.409e-07 |
2.677e-06 |
593 |
NEURON PROJECTION MORPHOGENESIS |
29 |
402 |
3.411e-07 |
2.677e-06 |
594 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
6 |
13 |
3.421e-07 |
2.68e-06 |
595 |
FOREBRAIN DEVELOPMENT |
27 |
357 |
3.445e-07 |
2.694e-06 |
596 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
10 |
50 |
3.519e-07 |
2.734e-06 |
597 |
STAT CASCADE |
10 |
50 |
3.519e-07 |
2.734e-06 |
598 |
JAK STAT CASCADE |
10 |
50 |
3.519e-07 |
2.734e-06 |
599 |
RESPONSE TO GAMMA RADIATION |
10 |
50 |
3.519e-07 |
2.734e-06 |
600 |
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
9 |
39 |
3.732e-07 |
2.886e-06 |
601 |
ASTROCYTE DIFFERENTIATION |
9 |
39 |
3.732e-07 |
2.886e-06 |
602 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
17 |
156 |
3.739e-07 |
2.886e-06 |
603 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
17 |
156 |
3.739e-07 |
2.886e-06 |
604 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
8 |
29 |
3.784e-07 |
2.905e-06 |
605 |
REGULATION OF HEART MORPHOGENESIS |
8 |
29 |
3.784e-07 |
2.905e-06 |
606 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
8 |
29 |
3.784e-07 |
2.905e-06 |
607 |
REGULATION OF EPIDERMIS DEVELOPMENT |
11 |
63 |
3.909e-07 |
2.996e-06 |
608 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
15 |
123 |
4.234e-07 |
3.241e-06 |
609 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
14 |
107 |
4.297e-07 |
3.279e-06 |
610 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
16 |
140 |
4.299e-07 |
3.279e-06 |
611 |
EAR DEVELOPMENT |
19 |
195 |
4.515e-07 |
3.439e-06 |
612 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
11 |
64 |
4.615e-07 |
3.509e-06 |
613 |
ENDOCRINE PANCREAS DEVELOPMENT |
9 |
40 |
4.71e-07 |
3.569e-06 |
614 |
ENDODERMAL CELL DIFFERENTIATION |
9 |
40 |
4.71e-07 |
3.569e-06 |
615 |
RENAL TUBULE DEVELOPMENT |
12 |
78 |
4.865e-07 |
3.681e-06 |
616 |
REGULATION OF JNK CASCADE |
17 |
159 |
4.913e-07 |
3.711e-06 |
617 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
13 |
93 |
5.113e-07 |
3.856e-06 |
618 |
POSITIVE REGULATION OF ION TRANSPORT |
21 |
236 |
5.166e-07 |
3.889e-06 |
619 |
CELLULAR RESPONSE TO RETINOIC ACID |
11 |
65 |
5.432e-07 |
4.084e-06 |
620 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
12 |
79 |
5.609e-07 |
4.209e-06 |
621 |
OSTEOBLAST DIFFERENTIATION |
15 |
126 |
5.803e-07 |
4.348e-06 |
622 |
T CELL MIGRATION |
6 |
14 |
5.861e-07 |
4.378e-06 |
623 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
6 |
14 |
5.861e-07 |
4.378e-06 |
624 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
9 |
41 |
5.903e-07 |
4.38e-06 |
625 |
AORTA DEVELOPMENT |
9 |
41 |
5.903e-07 |
4.38e-06 |
626 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
9 |
41 |
5.903e-07 |
4.38e-06 |
627 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
9 |
41 |
5.903e-07 |
4.38e-06 |
628 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
12 |
80 |
6.451e-07 |
4.78e-06 |
629 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
13 |
95 |
6.57e-07 |
4.86e-06 |
630 |
NEGATIVE REGULATION OF SECRETION |
19 |
200 |
6.667e-07 |
4.924e-06 |
631 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
7 |
22 |
7.016e-07 |
5.141e-06 |
632 |
REGULATION OF RESPONSE TO INTERFERON GAMMA |
7 |
22 |
7.016e-07 |
5.141e-06 |
633 |
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
7 |
22 |
7.016e-07 |
5.141e-06 |
634 |
AORTA MORPHOGENESIS |
7 |
22 |
7.016e-07 |
5.141e-06 |
635 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
17 |
163 |
6.996e-07 |
5.141e-06 |
636 |
REGULATION OF LIPID BIOSYNTHETIC PROCESS |
15 |
128 |
7.122e-07 |
5.211e-06 |
637 |
RESPONSE TO TOXIC SUBSTANCE |
21 |
241 |
7.293e-07 |
5.328e-06 |
638 |
REGULATION OF HEART GROWTH |
9 |
42 |
7.348e-07 |
5.359e-06 |
639 |
REGULATION OF FIBROBLAST PROLIFERATION |
12 |
81 |
7.405e-07 |
5.392e-06 |
640 |
PROTEIN COMPLEX BIOGENESIS |
56 |
1132 |
7.495e-07 |
5.435e-06 |
641 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
10 |
54 |
7.499e-07 |
5.435e-06 |
642 |
PROTEIN COMPLEX ASSEMBLY |
56 |
1132 |
7.495e-07 |
5.435e-06 |
643 |
BEHAVIOR |
33 |
516 |
8.266e-07 |
5.982e-06 |
644 |
REGULATION OF MUSCLE CONTRACTION |
16 |
147 |
8.359e-07 |
6.039e-06 |
645 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
26 |
351 |
8.438e-07 |
6.087e-06 |
646 |
KIDNEY MORPHOGENESIS |
12 |
82 |
8.481e-07 |
6.108e-06 |
647 |
SALIVARY GLAND DEVELOPMENT |
8 |
32 |
8.683e-07 |
6.225e-06 |
648 |
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT |
8 |
32 |
8.683e-07 |
6.225e-06 |
649 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
8 |
32 |
8.683e-07 |
6.225e-06 |
650 |
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION |
11 |
68 |
8.699e-07 |
6.227e-06 |
651 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
10 |
55 |
8.963e-07 |
6.406e-06 |
652 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
9 |
43 |
9.09e-07 |
6.477e-06 |
653 |
ACUTE PHASE RESPONSE |
9 |
43 |
9.09e-07 |
6.477e-06 |
654 |
DIGESTIVE SYSTEM DEVELOPMENT |
16 |
148 |
9.161e-07 |
6.517e-06 |
655 |
POSITIVE REGULATION OF ENDOCYTOSIS |
14 |
114 |
9.422e-07 |
6.693e-06 |
656 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
13 |
98 |
9.453e-07 |
6.705e-06 |
657 |
EMBRYONIC PLACENTA DEVELOPMENT |
12 |
83 |
9.693e-07 |
6.865e-06 |
658 |
RESPONSE TO INSULIN |
19 |
205 |
9.718e-07 |
6.872e-06 |
659 |
RESPONSE TO INCREASED OXYGEN LEVELS |
7 |
23 |
9.87e-07 |
6.948e-06 |
660 |
LEUKOCYTE APOPTOTIC PROCESS |
7 |
23 |
9.87e-07 |
6.948e-06 |
661 |
RESPONSE TO HYPEROXIA |
7 |
23 |
9.87e-07 |
6.948e-06 |
662 |
POSITIVE REGULATION OF AXONOGENESIS |
11 |
69 |
1.012e-06 |
7.113e-06 |
663 |
NEPHRON DEVELOPMENT |
14 |
115 |
1.049e-06 |
7.36e-06 |
664 |
LIPID PHOSPHORYLATION |
13 |
99 |
1.064e-06 |
7.455e-06 |
665 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
10 |
56 |
1.067e-06 |
7.467e-06 |
666 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
17 |
168 |
1.071e-06 |
7.483e-06 |
667 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
12 |
84 |
1.106e-06 |
7.713e-06 |
668 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
9 |
44 |
1.118e-06 |
7.774e-06 |
669 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
9 |
44 |
1.118e-06 |
7.774e-06 |
670 |
CELLULAR SENESCENCE |
8 |
33 |
1.121e-06 |
7.787e-06 |
671 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
19 |
208 |
1.211e-06 |
8.397e-06 |
672 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
12 |
85 |
1.259e-06 |
8.716e-06 |
673 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
10 |
57 |
1.266e-06 |
8.738e-06 |
674 |
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
10 |
57 |
1.266e-06 |
8.738e-06 |
675 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
11 |
71 |
1.358e-06 |
9.364e-06 |
676 |
EXOCRINE SYSTEM DEVELOPMENT |
9 |
45 |
1.367e-06 |
9.407e-06 |
677 |
SINGLE ORGANISM BEHAVIOR |
27 |
384 |
1.423e-06 |
9.781e-06 |
678 |
PROTEIN KINASE B SIGNALING |
8 |
34 |
1.435e-06 |
9.831e-06 |
679 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
8 |
34 |
1.435e-06 |
9.831e-06 |
680 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
18 |
191 |
1.471e-06 |
1.007e-05 |
681 |
EYE MORPHOGENESIS |
15 |
136 |
1.553e-06 |
1.061e-05 |
682 |
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS |
16 |
154 |
1.561e-06 |
1.065e-05 |
683 |
NEGATIVE REGULATION OF CYTOKINE SECRETION |
9 |
46 |
1.662e-06 |
1.132e-05 |
684 |
REGULATION OF CELL CYCLE PROCESS |
34 |
558 |
1.67e-06 |
1.136e-05 |
685 |
REGULATION OF CALCIUM ION IMPORT |
13 |
103 |
1.682e-06 |
1.142e-05 |
686 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
15 |
137 |
1.705e-06 |
1.154e-05 |
687 |
ACTIVATION OF MAPK ACTIVITY |
15 |
137 |
1.705e-06 |
1.154e-05 |
688 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
10 |
59 |
1.761e-06 |
1.191e-05 |
689 |
CELLULAR RESPONSE TO KETONE |
11 |
73 |
1.805e-06 |
1.217e-05 |
690 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
11 |
73 |
1.805e-06 |
1.217e-05 |
691 |
NEGATIVE REGULATION OF PROTEIN PROCESSING |
8 |
35 |
1.819e-06 |
1.223e-05 |
692 |
NEGATIVE REGULATION OF PROTEIN MATURATION |
8 |
35 |
1.819e-06 |
1.223e-05 |
693 |
MYELOID CELL HOMEOSTASIS |
12 |
88 |
1.837e-06 |
1.231e-05 |
694 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
12 |
88 |
1.837e-06 |
1.231e-05 |
695 |
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS |
16 |
156 |
1.853e-06 |
1.239e-05 |
696 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
16 |
156 |
1.853e-06 |
1.239e-05 |
697 |
REGULATION OF B CELL ACTIVATION |
14 |
121 |
1.946e-06 |
1.299e-05 |
698 |
SECRETION |
35 |
588 |
1.989e-06 |
1.326e-05 |
699 |
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
9 |
47 |
2.011e-06 |
1.338e-05 |
700 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
10 |
60 |
2.067e-06 |
1.374e-05 |
701 |
B CELL DIFFERENTIATION |
12 |
89 |
2.075e-06 |
1.376e-05 |
702 |
EPITHELIAL CELL PROLIFERATION |
12 |
89 |
2.075e-06 |
1.376e-05 |
703 |
CEREBRAL CORTEX DEVELOPMENT |
13 |
105 |
2.097e-06 |
1.388e-05 |
704 |
EMBRYONIC ORGAN MORPHOGENESIS |
22 |
279 |
2.132e-06 |
1.409e-05 |
705 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
22 |
280 |
2.262e-06 |
1.49e-05 |
706 |
NEGATIVE REGULATION OF ANOIKIS |
6 |
17 |
2.266e-06 |
1.49e-05 |
707 |
POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
6 |
17 |
2.266e-06 |
1.49e-05 |
708 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
6 |
17 |
2.266e-06 |
1.49e-05 |
709 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
8 |
36 |
2.289e-06 |
1.5e-05 |
710 |
T CELL SELECTION |
8 |
36 |
2.289e-06 |
1.5e-05 |
711 |
MESONEPHROS DEVELOPMENT |
12 |
90 |
2.341e-06 |
1.532e-05 |
712 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
14 |
123 |
2.371e-06 |
1.55e-05 |
713 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
11 |
75 |
2.376e-06 |
1.551e-05 |
714 |
REGULATION OF INTERLEUKIN 1 BETA PRODUCTION |
9 |
48 |
2.421e-06 |
1.577e-05 |
715 |
DEVELOPMENTAL PROGRAMMED CELL DEATH |
7 |
26 |
2.482e-06 |
1.615e-05 |
716 |
SENSORY ORGAN MORPHOGENESIS |
20 |
239 |
2.503e-06 |
1.627e-05 |
717 |
REGULATION OF T CELL DIFFERENTIATION |
13 |
107 |
2.6e-06 |
1.685e-05 |
718 |
RESPONSE TO RETINOIC ACID |
13 |
107 |
2.6e-06 |
1.685e-05 |
719 |
VESICLE MEDIATED TRANSPORT |
58 |
1239 |
2.699e-06 |
1.747e-05 |
720 |
REGULATION OF DNA REPLICATION |
16 |
161 |
2.81e-06 |
1.816e-05 |
721 |
MYOBLAST DIFFERENTIATION |
8 |
37 |
2.857e-06 |
1.841e-05 |
722 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
8 |
37 |
2.857e-06 |
1.841e-05 |
723 |
KIDNEY EPITHELIUM DEVELOPMENT |
14 |
125 |
2.877e-06 |
1.851e-05 |
724 |
REGULATION OF CELL CYCLE ARREST |
13 |
108 |
2.89e-06 |
1.857e-05 |
725 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
9 |
49 |
2.9e-06 |
1.859e-05 |
726 |
LYMPHOCYTE MIGRATION |
9 |
49 |
2.9e-06 |
1.859e-05 |
727 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
15 |
143 |
2.928e-06 |
1.874e-05 |
728 |
REGULATION OF BMP SIGNALING PATHWAY |
11 |
77 |
3.099e-06 |
1.981e-05 |
729 |
REGULATION OF MICROTUBULE BASED PROCESS |
20 |
243 |
3.227e-06 |
2.06e-05 |
730 |
DETECTION OF BIOTIC STIMULUS |
7 |
27 |
3.279e-06 |
2.084e-05 |
731 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
7 |
27 |
3.279e-06 |
2.084e-05 |
732 |
REGULATION OF MUSCLE ADAPTATION |
10 |
63 |
3.278e-06 |
2.084e-05 |
733 |
NEPHRON EPITHELIUM DEVELOPMENT |
12 |
93 |
3.329e-06 |
2.11e-05 |
734 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
6 |
18 |
3.328e-06 |
2.11e-05 |
735 |
ENDODERM FORMATION |
9 |
50 |
3.46e-06 |
2.19e-05 |
736 |
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
10 |
64 |
3.799e-06 |
2.402e-05 |
737 |
POSITIVE REGULATION OF HAIR CYCLE |
5 |
11 |
3.829e-06 |
2.417e-05 |
738 |
CELL JUNCTION ORGANIZATION |
17 |
185 |
4.049e-06 |
2.553e-05 |
739 |
ARTERY MORPHOGENESIS |
9 |
51 |
4.109e-06 |
2.587e-05 |
740 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
20 |
247 |
4.136e-06 |
2.6e-05 |
741 |
REGULATION OF EPITHELIAL CELL MIGRATION |
16 |
166 |
4.189e-06 |
2.631e-05 |
742 |
RESPONSE TO COPPER ION |
7 |
28 |
4.279e-06 |
2.683e-05 |
743 |
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
8 |
39 |
4.358e-06 |
2.722e-05 |
744 |
REGULATION OF GRANULOCYTE CHEMOTAXIS |
8 |
39 |
4.358e-06 |
2.722e-05 |
745 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
8 |
39 |
4.358e-06 |
2.722e-05 |
746 |
PEPTIDYL SERINE MODIFICATION |
15 |
148 |
4.494e-06 |
2.803e-05 |
747 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
12 |
96 |
4.666e-06 |
2.906e-05 |
748 |
DETECTION OF OTHER ORGANISM |
6 |
19 |
4.762e-06 |
2.962e-05 |
749 |
OVULATION CYCLE |
13 |
113 |
4.812e-06 |
2.989e-05 |
750 |
ACTIVATION OF MAPKK ACTIVITY |
9 |
52 |
4.861e-06 |
3.016e-05 |
751 |
REGULATION OF AXONOGENESIS |
16 |
168 |
4.893e-06 |
3.031e-05 |
752 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
20 |
250 |
4.963e-06 |
3.071e-05 |
753 |
NEGATIVE REGULATION OF BINDING |
14 |
131 |
5.017e-06 |
3.1e-05 |
754 |
REGULATION OF CELL DIVISION |
21 |
272 |
5.045e-06 |
3.109e-05 |
755 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
21 |
272 |
5.045e-06 |
3.109e-05 |
756 |
MESODERM MORPHOGENESIS |
10 |
66 |
5.061e-06 |
3.111e-05 |
757 |
REGULATION OF VASOCONSTRICTION |
10 |
66 |
5.061e-06 |
3.111e-05 |
758 |
METANEPHROS DEVELOPMENT |
11 |
81 |
5.142e-06 |
3.156e-05 |
759 |
REGULATION OF INTERFERON GAMMA PRODUCTION |
12 |
97 |
5.206e-06 |
3.192e-05 |
760 |
REGULATION OF BLOOD CIRCULATION |
22 |
295 |
5.278e-06 |
3.232e-05 |
761 |
MAMMARY GLAND MORPHOGENESIS |
8 |
40 |
5.329e-06 |
3.258e-05 |
762 |
LEUKOCYTE MEDIATED IMMUNITY |
17 |
189 |
5.405e-06 |
3.3e-05 |
763 |
B CELL ACTIVATION |
14 |
132 |
5.487e-06 |
3.346e-05 |
764 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
7 |
29 |
5.52e-06 |
3.362e-05 |
765 |
LIPID MODIFICATION |
18 |
210 |
5.67e-06 |
3.449e-05 |
766 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
9 |
53 |
5.728e-06 |
3.47e-05 |
767 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
9 |
53 |
5.728e-06 |
3.47e-05 |
768 |
MESONEPHRIC TUBULE MORPHOGENESIS |
9 |
53 |
5.728e-06 |
3.47e-05 |
769 |
RECEPTOR METABOLIC PROCESS |
11 |
82 |
5.807e-06 |
3.509e-05 |
770 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
11 |
82 |
5.807e-06 |
3.509e-05 |
771 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
15 |
152 |
6.246e-06 |
3.769e-05 |
772 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
25 |
368 |
6.382e-06 |
3.847e-05 |
773 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
13 |
116 |
6.445e-06 |
3.874e-05 |
774 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
13 |
116 |
6.445e-06 |
3.874e-05 |
775 |
MYELOID LEUKOCYTE MIGRATION |
12 |
99 |
6.454e-06 |
3.875e-05 |
776 |
REGULATION OF LIPASE ACTIVITY |
11 |
83 |
6.546e-06 |
3.925e-05 |
777 |
REGULATION OF CELL SIZE |
16 |
172 |
6.625e-06 |
3.967e-05 |
778 |
PROTEIN AUTOPHOSPHORYLATION |
17 |
192 |
6.676e-06 |
3.992e-05 |
779 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
26 |
393 |
6.716e-06 |
4.012e-05 |
780 |
MACROMOLECULAR COMPLEX ASSEMBLY |
62 |
1398 |
6.737e-06 |
4.019e-05 |
781 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
15 |
153 |
6.769e-06 |
4.033e-05 |
782 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
7 |
30 |
7.046e-06 |
4.177e-05 |
783 |
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
7 |
30 |
7.046e-06 |
4.177e-05 |
784 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
7 |
30 |
7.046e-06 |
4.177e-05 |
785 |
OSTEOCLAST DIFFERENTIATION |
7 |
30 |
7.046e-06 |
4.177e-05 |
786 |
REGULATION OF PEPTIDE TRANSPORT |
20 |
256 |
7.082e-06 |
4.191e-05 |
787 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
45 |
898 |
7.089e-06 |
4.191e-05 |
788 |
REGULATION OF CELL SUBSTRATE ADHESION |
16 |
173 |
7.136e-06 |
4.214e-05 |
789 |
MEMBRANE ORGANIZATION |
45 |
899 |
7.293e-06 |
4.301e-05 |
790 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
8 |
42 |
7.829e-06 |
4.611e-05 |
791 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
9 |
55 |
7.863e-06 |
4.625e-05 |
792 |
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
11 |
85 |
8.274e-06 |
4.861e-05 |
793 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
18 |
216 |
8.386e-06 |
4.92e-05 |
794 |
RESPONSE TO ALKALOID |
14 |
137 |
8.47e-06 |
4.964e-05 |
795 |
B CELL HOMEOSTASIS |
6 |
21 |
9.129e-06 |
5.343e-05 |
796 |
DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM |
8 |
43 |
9.411e-06 |
5.501e-05 |
797 |
ACTIN FILAMENT BASED PROCESS |
28 |
450 |
9.454e-06 |
5.52e-05 |
798 |
REGULATION OF CIRCADIAN RHYTHM |
12 |
103 |
9.758e-06 |
5.69e-05 |
799 |
ENDODERM DEVELOPMENT |
10 |
71 |
9.912e-06 |
5.772e-05 |
800 |
CARDIOBLAST DIFFERENTIATION |
5 |
13 |
1.023e-05 |
5.938e-05 |
801 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
13 |
1.023e-05 |
5.938e-05 |
802 |
NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
13 |
1.023e-05 |
5.938e-05 |
803 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
21 |
285 |
1.035e-05 |
6e-05 |
804 |
ENDOCARDIAL CUSHION DEVELOPMENT |
7 |
32 |
1.116e-05 |
6.434e-05 |
805 |
PATTERNING OF BLOOD VESSELS |
7 |
32 |
1.116e-05 |
6.434e-05 |
806 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
7 |
32 |
1.116e-05 |
6.434e-05 |
807 |
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
7 |
32 |
1.116e-05 |
6.434e-05 |
808 |
ENDOTHELIAL CELL DIFFERENTIATION |
10 |
72 |
1.126e-05 |
6.451e-05 |
809 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
8 |
44 |
1.125e-05 |
6.451e-05 |
810 |
CHEMOKINE MEDIATED SIGNALING PATHWAY |
10 |
72 |
1.126e-05 |
6.451e-05 |
811 |
DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM |
10 |
72 |
1.126e-05 |
6.451e-05 |
812 |
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
8 |
44 |
1.125e-05 |
6.451e-05 |
813 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
6 |
22 |
1.229e-05 |
6.999e-05 |
814 |
REGULATION OF HAIR CYCLE |
6 |
22 |
1.229e-05 |
6.999e-05 |
815 |
REGULATION OF INTERLEUKIN 17 PRODUCTION |
6 |
22 |
1.229e-05 |
6.999e-05 |
816 |
REGULATION OF CELLULAR RESPIRATION |
6 |
22 |
1.229e-05 |
6.999e-05 |
817 |
CELLULAR RESPONSE TO INTERLEUKIN 6 |
6 |
22 |
1.229e-05 |
6.999e-05 |
818 |
SEX DIFFERENTIATION |
20 |
266 |
1.248e-05 |
7.099e-05 |
819 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
10 |
73 |
1.276e-05 |
7.248e-05 |
820 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
22 |
312 |
1.281e-05 |
7.262e-05 |
821 |
EPIDERMAL CELL DIFFERENTIATION |
14 |
142 |
1.281e-05 |
7.262e-05 |
822 |
RESPONSE TO HEAT |
11 |
89 |
1.295e-05 |
7.331e-05 |
823 |
DNA TEMPLATED TRANSCRIPTION INITIATION |
17 |
202 |
1.307e-05 |
7.391e-05 |
824 |
DENDRITIC CELL DIFFERENTIATION |
7 |
33 |
1.386e-05 |
7.789e-05 |
825 |
RESPONSE TO VITAMIN D |
7 |
33 |
1.386e-05 |
7.789e-05 |
826 |
NEGATIVE REGULATION OF JNK CASCADE |
7 |
33 |
1.386e-05 |
7.789e-05 |
827 |
RESPONSE TO DEXAMETHASONE |
7 |
33 |
1.386e-05 |
7.789e-05 |
828 |
REGULATION OF CELL AGING |
7 |
33 |
1.386e-05 |
7.789e-05 |
829 |
LIPID METABOLIC PROCESS |
53 |
1158 |
1.411e-05 |
7.921e-05 |
830 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
11 |
90 |
1.443e-05 |
8.069e-05 |
831 |
ENDOTHELIUM DEVELOPMENT |
11 |
90 |
1.443e-05 |
8.069e-05 |
832 |
REGULATION OF STEROID METABOLIC PROCESS |
10 |
74 |
1.443e-05 |
8.069e-05 |
833 |
CARDIAC CHAMBER DEVELOPMENT |
14 |
144 |
1.503e-05 |
8.397e-05 |
834 |
CHROMATIN MODIFICATION |
31 |
539 |
1.516e-05 |
8.461e-05 |
835 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
28 |
462 |
1.532e-05 |
8.539e-05 |
836 |
REGULATION OF PODOSOME ASSEMBLY |
5 |
14 |
1.559e-05 |
8.638e-05 |
837 |
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
5 |
14 |
1.559e-05 |
8.638e-05 |
838 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
5 |
14 |
1.559e-05 |
8.638e-05 |
839 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
5 |
14 |
1.559e-05 |
8.638e-05 |
840 |
POST EMBRYONIC ORGAN DEVELOPMENT |
5 |
14 |
1.559e-05 |
8.638e-05 |
841 |
CELL SUBSTRATE ADHESION |
15 |
164 |
1.569e-05 |
8.681e-05 |
842 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
12 |
108 |
1.591e-05 |
8.779e-05 |
843 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
12 |
108 |
1.591e-05 |
8.779e-05 |
844 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
13 |
126 |
1.596e-05 |
8.798e-05 |
845 |
REGULATION OF NUCLEASE ACTIVITY |
6 |
23 |
1.628e-05 |
8.912e-05 |
846 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
6 |
23 |
1.628e-05 |
8.912e-05 |
847 |
CELLULAR GLUCOSE HOMEOSTASIS |
10 |
75 |
1.628e-05 |
8.912e-05 |
848 |
REGULATION OF METANEPHROS DEVELOPMENT |
6 |
23 |
1.628e-05 |
8.912e-05 |
849 |
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS |
6 |
23 |
1.628e-05 |
8.912e-05 |
850 |
NEUROTROPHIN SIGNALING PATHWAY |
6 |
23 |
1.628e-05 |
8.912e-05 |
851 |
REGULATION OF MONOOXYGENASE ACTIVITY |
9 |
60 |
1.637e-05 |
8.953e-05 |
852 |
RESPONSE TO FLUID SHEAR STRESS |
7 |
34 |
1.708e-05 |
9.296e-05 |
853 |
T CELL HOMEOSTASIS |
7 |
34 |
1.708e-05 |
9.296e-05 |
854 |
HEART VALVE DEVELOPMENT |
7 |
34 |
1.708e-05 |
9.296e-05 |
855 |
CELLULAR RESPONSE TO ALKALOID |
7 |
34 |
1.708e-05 |
9.296e-05 |
856 |
NEGATIVE REGULATION OF ION TRANSPORT |
13 |
127 |
1.738e-05 |
9.449e-05 |
857 |
COGNITION |
19 |
251 |
1.865e-05 |
0.0001013 |
858 |
REGULATION OF IMMUNOGLOBULIN PRODUCTION |
8 |
47 |
1.87e-05 |
0.0001013 |
859 |
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS |
8 |
47 |
1.87e-05 |
0.0001013 |
860 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
9 |
61 |
1.879e-05 |
0.0001017 |
861 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
13 |
128 |
1.892e-05 |
0.0001022 |
862 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
22 |
321 |
1.991e-05 |
0.0001075 |
863 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
17 |
209 |
2.037e-05 |
0.0001098 |
864 |
RESPONSE TO TEMPERATURE STIMULUS |
14 |
148 |
2.052e-05 |
0.0001105 |
865 |
MITOTIC CELL CYCLE |
39 |
766 |
2.075e-05 |
0.0001116 |
866 |
POSITIVE REGULATION OF VASOCONSTRICTION |
7 |
35 |
2.09e-05 |
0.0001122 |
867 |
BONE REMODELING |
7 |
35 |
2.09e-05 |
0.0001122 |
868 |
RECEPTOR MEDIATED ENDOCYTOSIS |
18 |
231 |
2.092e-05 |
0.0001122 |
869 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
6 |
24 |
2.125e-05 |
0.0001131 |
870 |
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION |
6 |
24 |
2.125e-05 |
0.0001131 |
871 |
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
6 |
24 |
2.125e-05 |
0.0001131 |
872 |
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION |
6 |
24 |
2.125e-05 |
0.0001131 |
873 |
REGULATION OF ISOTYPE SWITCHING |
6 |
24 |
2.125e-05 |
0.0001131 |
874 |
REGULATION OF ANOIKIS |
6 |
24 |
2.125e-05 |
0.0001131 |
875 |
FOREBRAIN CELL MIGRATION |
9 |
62 |
2.15e-05 |
0.0001142 |
876 |
CARDIAC VENTRICLE MORPHOGENESIS |
9 |
62 |
2.15e-05 |
0.0001142 |
877 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
22 |
323 |
2.19e-05 |
0.0001162 |
878 |
REGULATION OF MYOBLAST DIFFERENTIATION |
8 |
48 |
2.196e-05 |
0.0001162 |
879 |
POSITIVE REGULATION OF WOUND HEALING |
8 |
48 |
2.196e-05 |
0.0001162 |
880 |
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
5 |
15 |
2.291e-05 |
0.0001203 |
881 |
REGULATION OF HAIR FOLLICLE DEVELOPMENT |
5 |
15 |
2.291e-05 |
0.0001203 |
882 |
NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION |
5 |
15 |
2.291e-05 |
0.0001203 |
883 |
NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION |
5 |
15 |
2.291e-05 |
0.0001203 |
884 |
POSITIVE REGULATION OF NUCLEASE ACTIVITY |
5 |
15 |
2.291e-05 |
0.0001203 |
885 |
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS |
5 |
15 |
2.291e-05 |
0.0001203 |
886 |
T CELL APOPTOTIC PROCESS |
5 |
15 |
2.291e-05 |
0.0001203 |
887 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
17 |
211 |
2.303e-05 |
0.0001208 |
888 |
PHAGOCYTOSIS |
16 |
190 |
2.319e-05 |
0.0001215 |
889 |
CATABOLIC PROCESS |
72 |
1773 |
2.363e-05 |
0.0001237 |
890 |
REGULATION OF OSTEOCLAST DIFFERENTIATION |
9 |
63 |
2.454e-05 |
0.0001281 |
891 |
RESPONSE TO OSMOTIC STRESS |
9 |
63 |
2.454e-05 |
0.0001281 |
892 |
DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE |
7 |
36 |
2.539e-05 |
0.0001324 |
893 |
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY |
8 |
49 |
2.568e-05 |
0.0001338 |
894 |
NEGATIVE REGULATION OF PROTEIN BINDING |
10 |
79 |
2.589e-05 |
0.0001348 |
895 |
RESPONSE TO LIGHT STIMULUS |
20 |
280 |
2.623e-05 |
0.0001363 |
896 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
11 |
96 |
2.675e-05 |
0.0001389 |
897 |
MONOCARBOXYLIC ACID METABOLIC PROCESS |
29 |
503 |
2.729e-05 |
0.0001416 |
898 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
26 |
426 |
2.732e-05 |
0.0001416 |
899 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
6 |
25 |
2.738e-05 |
0.0001417 |
900 |
FATTY ACID BIOSYNTHETIC PROCESS |
12 |
114 |
2.753e-05 |
0.0001423 |
901 |
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS |
15 |
172 |
2.759e-05 |
0.0001425 |
902 |
CHROMOSOME ORGANIZATION |
47 |
1009 |
2.876e-05 |
0.0001483 |
903 |
MUSCLE SYSTEM PROCESS |
20 |
282 |
2.903e-05 |
0.0001496 |
904 |
CELLULAR RESPONSE TO CAMP |
8 |
50 |
2.991e-05 |
0.000154 |
905 |
CELL CYCLE CHECKPOINT |
16 |
194 |
2.996e-05 |
0.0001541 |
906 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
7 |
37 |
3.065e-05 |
0.0001574 |
907 |
REGULATION OF RESPONSE TO OXIDATIVE STRESS |
9 |
65 |
3.172e-05 |
0.0001627 |
908 |
REGULATION OF JUN KINASE ACTIVITY |
10 |
81 |
3.229e-05 |
0.0001655 |
909 |
MYELOID LEUKOCYTE ACTIVATION |
11 |
98 |
3.25e-05 |
0.0001664 |
910 |
REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
5 |
16 |
3.265e-05 |
0.0001664 |
911 |
REGULATION OF MONONUCLEAR CELL MIGRATION |
5 |
16 |
3.265e-05 |
0.0001664 |
912 |
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS |
5 |
16 |
3.265e-05 |
0.0001664 |
913 |
REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS |
5 |
16 |
3.265e-05 |
0.0001664 |
914 |
REGULATION OF CELLULAR SENESCENCE |
6 |
26 |
3.484e-05 |
0.0001766 |
915 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
26 |
3.484e-05 |
0.0001766 |
916 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
8 |
51 |
3.471e-05 |
0.0001766 |
917 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
6 |
26 |
3.484e-05 |
0.0001766 |
918 |
RESPONSE TO INTERLEUKIN 6 |
6 |
26 |
3.484e-05 |
0.0001766 |
919 |
NEGATIVE REGULATION OF LOCOMOTION |
19 |
263 |
3.557e-05 |
0.0001801 |
920 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
9 |
66 |
3.592e-05 |
0.0001813 |
921 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
9 |
66 |
3.592e-05 |
0.0001813 |
922 |
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS |
9 |
66 |
3.592e-05 |
0.0001813 |
923 |
REGULATION OF PROTEIN MATURATION |
10 |
82 |
3.597e-05 |
0.0001813 |
924 |
LYMPHOCYTE CHEMOTAXIS |
7 |
38 |
3.677e-05 |
0.000185 |
925 |
MESENCHYME MORPHOGENESIS |
7 |
38 |
3.677e-05 |
0.000185 |
926 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
14 |
156 |
3.701e-05 |
0.0001858 |
927 |
PROTEIN LOCALIZATION TO NUCLEUS |
14 |
156 |
3.701e-05 |
0.0001858 |
928 |
SEXUAL REPRODUCTION |
37 |
730 |
3.728e-05 |
0.0001869 |
929 |
MESODERM DEVELOPMENT |
12 |
118 |
3.888e-05 |
0.0001947 |
930 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
11 |
100 |
3.929e-05 |
0.0001964 |
931 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
11 |
100 |
3.929e-05 |
0.0001964 |
932 |
REGULATION OF CELLULAR COMPONENT SIZE |
22 |
337 |
4.167e-05 |
0.000208 |
933 |
VIRAL LIFE CYCLE |
20 |
290 |
4.313e-05 |
0.0002151 |
934 |
SKELETAL MUSCLE TISSUE REGENERATION |
6 |
27 |
4.386e-05 |
0.0002176 |
935 |
POSITIVE REGULATION OF HEART GROWTH |
6 |
27 |
4.386e-05 |
0.0002176 |
936 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
7 |
39 |
4.386e-05 |
0.0002176 |
937 |
AXIS ELONGATION |
6 |
27 |
4.386e-05 |
0.0002176 |
938 |
PLATELET AGGREGATION |
7 |
39 |
4.386e-05 |
0.0002176 |
939 |
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
5 |
17 |
4.531e-05 |
0.000224 |
940 |
MEMBRANE RAFT ORGANIZATION |
5 |
17 |
4.531e-05 |
0.000224 |
941 |
REGULATION OF RECEPTOR BINDING |
5 |
17 |
4.531e-05 |
0.000224 |
942 |
MITOTIC CELL CYCLE CHECKPOINT |
13 |
139 |
4.54e-05 |
0.0002242 |
943 |
REGULATION OF CELL JUNCTION ASSEMBLY |
9 |
68 |
4.577e-05 |
0.0002254 |
944 |
REGULATION OF NEUROLOGICAL SYSTEM PROCESS |
9 |
68 |
4.577e-05 |
0.0002254 |
945 |
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
9 |
68 |
4.577e-05 |
0.0002254 |
946 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
53 |
4.625e-05 |
0.0002275 |
947 |
CELLULAR LIPID METABOLIC PROCESS |
43 |
913 |
4.944e-05 |
0.0002429 |
948 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
12 |
121 |
4.987e-05 |
0.0002448 |
949 |
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION |
9 |
69 |
5.149e-05 |
0.0002522 |
950 |
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
9 |
69 |
5.149e-05 |
0.0002522 |
951 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
16 |
203 |
5.193e-05 |
0.0002541 |
952 |
RESPONSE TO CADMIUM ION |
7 |
40 |
5.203e-05 |
0.0002543 |
953 |
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS |
8 |
54 |
5.313e-05 |
0.0002594 |
954 |
PATTERN SPECIFICATION PROCESS |
25 |
418 |
5.403e-05 |
0.0002635 |
955 |
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
6 |
28 |
5.466e-05 |
0.0002646 |
956 |
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
6 |
28 |
5.466e-05 |
0.0002646 |
957 |
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
6 |
28 |
5.466e-05 |
0.0002646 |
958 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
6 |
28 |
5.466e-05 |
0.0002646 |
959 |
NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
6 |
28 |
5.466e-05 |
0.0002646 |
960 |
REGULATION OF MULTI ORGANISM PROCESS |
27 |
470 |
5.471e-05 |
0.0002646 |
961 |
POSITIVE REGULATION OF B CELL ACTIVATION |
10 |
86 |
5.449e-05 |
0.0002646 |
962 |
MAMMARY GLAND DUCT MORPHOGENESIS |
6 |
28 |
5.466e-05 |
0.0002646 |
963 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
14 |
162 |
5.609e-05 |
0.000271 |
964 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
11 |
104 |
5.659e-05 |
0.0002732 |
965 |
CELL PART MORPHOGENESIS |
33 |
633 |
5.739e-05 |
0.0002767 |
966 |
I KAPPAB KINASE NF KAPPAB SIGNALING |
9 |
70 |
5.78e-05 |
0.0002784 |
967 |
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN |
14 |
163 |
5.999e-05 |
0.0002887 |
968 |
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION |
5 |
18 |
6.145e-05 |
0.0002921 |
969 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
55 |
6.083e-05 |
0.0002921 |
970 |
NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY |
7 |
41 |
6.141e-05 |
0.0002921 |
971 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
5 |
18 |
6.145e-05 |
0.0002921 |
972 |
RAS PROTEIN SIGNAL TRANSDUCTION |
13 |
143 |
6.1e-05 |
0.0002921 |
973 |
REGULATION OF B CELL MEDIATED IMMUNITY |
7 |
41 |
6.141e-05 |
0.0002921 |
974 |
CHROMATIN ORGANIZATION |
34 |
663 |
6.134e-05 |
0.0002921 |
975 |
REGULATION OF MYOTUBE DIFFERENTIATION |
8 |
55 |
6.083e-05 |
0.0002921 |
976 |
PHARYNGEAL SYSTEM DEVELOPMENT |
5 |
18 |
6.145e-05 |
0.0002921 |
977 |
PROSTATE GLAND DEVELOPMENT |
7 |
41 |
6.141e-05 |
0.0002921 |
978 |
LYMPHOCYTE APOPTOTIC PROCESS |
5 |
18 |
6.145e-05 |
0.0002921 |
979 |
MUSCLE CELL MIGRATION |
5 |
18 |
6.145e-05 |
0.0002921 |
980 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
12 |
124 |
6.344e-05 |
0.0003012 |
981 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
6 |
29 |
6.748e-05 |
0.0003194 |
982 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
11 |
106 |
6.746e-05 |
0.0003194 |
983 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
6 |
29 |
6.748e-05 |
0.0003194 |
984 |
SYNAPSE ORGANIZATION |
13 |
145 |
7.042e-05 |
0.000333 |
985 |
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
7 |
42 |
7.213e-05 |
0.00034 |
986 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
7 |
42 |
7.213e-05 |
0.00034 |
987 |
EPITHELIAL CELL MORPHOGENESIS |
7 |
42 |
7.213e-05 |
0.00034 |
988 |
REGULATION OF HORMONE LEVELS |
27 |
478 |
7.271e-05 |
0.0003424 |
989 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
10 |
89 |
7.323e-05 |
0.0003445 |
990 |
RESPONSE TO UV |
12 |
126 |
7.417e-05 |
0.0003486 |
991 |
REGULATION OF CHROMOSOME ORGANIZATION |
19 |
278 |
7.515e-05 |
0.0003528 |
992 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
13 |
146 |
7.558e-05 |
0.0003542 |
993 |
DNA INTEGRITY CHECKPOINT |
13 |
146 |
7.558e-05 |
0.0003542 |
994 |
CALCIUM MEDIATED SIGNALING |
10 |
90 |
8.057e-05 |
0.0003764 |
995 |
REGULATION OF CELL MATRIX ADHESION |
10 |
90 |
8.057e-05 |
0.0003764 |
996 |
REGULATION OF GLIOGENESIS |
10 |
90 |
8.057e-05 |
0.0003764 |
997 |
POSITIVE REGULATION OF PROTEIN BINDING |
9 |
73 |
8.079e-05 |
0.0003767 |
998 |
PANCREAS DEVELOPMENT |
9 |
73 |
8.079e-05 |
0.0003767 |
999 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
5 |
19 |
8.17e-05 |
0.0003771 |
1000 |
FIBRIL ORGANIZATION |
5 |
19 |
8.17e-05 |
0.0003771 |
1001 |
REGULATION OF WATER LOSS VIA SKIN |
5 |
19 |
8.17e-05 |
0.0003771 |
1002 |
MUSCLE CELL PROLIFERATION |
5 |
19 |
8.17e-05 |
0.0003771 |
1003 |
REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
5 |
19 |
8.17e-05 |
0.0003771 |
1004 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
13 |
147 |
8.107e-05 |
0.0003771 |
1005 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
5 |
19 |
8.17e-05 |
0.0003771 |
1006 |
REGULATION OF INTERLEUKIN 8 SECRETION |
5 |
19 |
8.17e-05 |
0.0003771 |
1007 |
MACROPHAGE DIFFERENTIATION |
5 |
19 |
8.17e-05 |
0.0003771 |
1008 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
5 |
19 |
8.17e-05 |
0.0003771 |
1009 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
6 |
30 |
8.259e-05 |
0.0003808 |
1010 |
CELL FATE DETERMINATION |
7 |
43 |
8.432e-05 |
0.0003885 |
1011 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
22 |
354 |
8.622e-05 |
0.0003968 |
1012 |
NEGATIVE REGULATION OF HEMOPOIESIS |
12 |
128 |
8.642e-05 |
0.000397 |
1013 |
MUSCLE CELL DEVELOPMENT |
12 |
128 |
8.642e-05 |
0.000397 |
1014 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
11 |
109 |
8.71e-05 |
0.0003993 |
1015 |
UNSATURATED FATTY ACID METABOLIC PROCESS |
11 |
109 |
8.71e-05 |
0.0003993 |
1016 |
POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
8 |
58 |
8.972e-05 |
0.0004109 |
1017 |
REGULATION OF ACUTE INFLAMMATORY RESPONSE |
9 |
74 |
8.998e-05 |
0.0004117 |
1018 |
SECRETION BY CELL |
27 |
486 |
9.587e-05 |
0.0004382 |
1019 |
CELL DIVISION |
26 |
460 |
9.754e-05 |
0.0004454 |
1020 |
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
7 |
44 |
9.814e-05 |
0.0004477 |
1021 |
RESPONSE TO INTERLEUKIN 4 |
6 |
31 |
0.0001003 |
0.0004556 |
1022 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
6 |
31 |
0.0001003 |
0.0004556 |
1023 |
GRANULOCYTE MIGRATION |
9 |
75 |
1e-04 |
0.0004556 |
1024 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
6 |
31 |
0.0001003 |
0.0004556 |
1025 |
TISSUE HOMEOSTASIS |
14 |
171 |
0.0001007 |
0.0004571 |
1026 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
8 |
59 |
0.0001016 |
0.0004602 |
1027 |
VASCULOGENESIS |
8 |
59 |
0.0001016 |
0.0004602 |
1028 |
RESPONSE TO PROTOZOAN |
5 |
20 |
0.0001067 |
0.0004816 |
1029 |
RESPONSE TO LIPOPROTEIN PARTICLE |
5 |
20 |
0.0001067 |
0.0004816 |
1030 |
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
5 |
20 |
0.0001067 |
0.0004816 |
1031 |
MYELOID DENDRITIC CELL DIFFERENTIATION |
5 |
20 |
0.0001067 |
0.0004816 |
1032 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
12 |
131 |
0.0001081 |
0.0004867 |
1033 |
REGULATION OF HORMONE SECRETION |
18 |
262 |
0.0001081 |
0.0004867 |
1034 |
POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
11 |
0.0001091 |
0.0004879 |
1035 |
CARDIAC CELL FATE COMMITMENT |
4 |
11 |
0.0001091 |
0.0004879 |
1036 |
DETECTION OF MOLECULE OF BACTERIAL ORIGIN |
4 |
11 |
0.0001091 |
0.0004879 |
1037 |
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS |
4 |
11 |
0.0001091 |
0.0004879 |
1038 |
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE |
4 |
11 |
0.0001091 |
0.0004879 |
1039 |
NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION |
4 |
11 |
0.0001091 |
0.0004879 |
1040 |
REGULATION OF NECROPTOTIC PROCESS |
4 |
11 |
0.0001091 |
0.0004879 |
1041 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
9 |
76 |
0.000111 |
0.0004961 |
1042 |
THYMOCYTE AGGREGATION |
7 |
45 |
0.0001138 |
0.0005055 |
1043 |
SPROUTING ANGIOGENESIS |
7 |
45 |
0.0001138 |
0.0005055 |
1044 |
T CELL DIFFERENTIATION IN THYMUS |
7 |
45 |
0.0001138 |
0.0005055 |
1045 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
7 |
45 |
0.0001138 |
0.0005055 |
1046 |
NEGATIVE REGULATION OF CHROMATIN MODIFICATION |
7 |
45 |
0.0001138 |
0.0005055 |
1047 |
ENDOCHONDRAL BONE MORPHOGENESIS |
7 |
45 |
0.0001138 |
0.0005055 |
1048 |
REGULATION OF CHROMATIN ORGANIZATION |
13 |
152 |
0.000114 |
0.0005057 |
1049 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
13 |
152 |
0.000114 |
0.0005057 |
1050 |
OLIGODENDROCYTE DIFFERENTIATION |
8 |
60 |
0.0001147 |
0.0005081 |
1051 |
SMALL MOLECULE METABOLIC PROCESS |
69 |
1767 |
0.0001185 |
0.0005244 |
1052 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
12 |
133 |
0.0001249 |
0.0005521 |
1053 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
12 |
133 |
0.0001249 |
0.0005521 |
1054 |
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY |
8 |
61 |
0.0001291 |
0.0005701 |
1055 |
PROTEIN LOCALIZATION |
70 |
1805 |
0.0001293 |
0.0005704 |
1056 |
ORGANIC ACID METABOLIC PROCESS |
43 |
953 |
0.0001295 |
0.0005706 |
1057 |
NOTCH SIGNALING PATHWAY |
11 |
114 |
0.0001307 |
0.0005752 |
1058 |
REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH |
7 |
46 |
0.0001313 |
0.000577 |
1059 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
7 |
46 |
0.0001313 |
0.000577 |
1060 |
LYMPHOCYTE COSTIMULATION |
9 |
78 |
0.000136 |
0.0005969 |
1061 |
CELL AGGREGATION |
5 |
21 |
0.0001372 |
0.0006006 |
1062 |
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT |
5 |
21 |
0.0001372 |
0.0006006 |
1063 |
CARTILAGE CONDENSATION |
5 |
21 |
0.0001372 |
0.0006006 |
1064 |
REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
10 |
96 |
0.0001391 |
0.0006084 |
1065 |
POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION |
6 |
33 |
0.0001446 |
0.0006294 |
1066 |
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
6 |
33 |
0.0001446 |
0.0006294 |
1067 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
6 |
33 |
0.0001446 |
0.0006294 |
1068 |
REGULATION OF INTERLEUKIN 1 SECRETION |
6 |
33 |
0.0001446 |
0.0006294 |
1069 |
CELLULAR MACROMOLECULE LOCALIZATION |
52 |
1234 |
0.0001446 |
0.0006294 |
1070 |
REGULATION OF TISSUE REMODELING |
8 |
62 |
0.0001451 |
0.0006309 |
1071 |
ERBB SIGNALING PATHWAY |
9 |
79 |
0.0001501 |
0.0006523 |
1072 |
POSITIVE REGULATION OF GLIOGENESIS |
7 |
47 |
0.000151 |
0.0006556 |
1073 |
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION |
14 |
178 |
0.0001541 |
0.0006684 |
1074 |
POSITIVE REGULATION OF CELLULAR EXTRAVASATION |
4 |
12 |
0.0001604 |
0.0006909 |
1075 |
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION |
4 |
12 |
0.0001604 |
0.0006909 |
1076 |
POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
4 |
12 |
0.0001604 |
0.0006909 |
1077 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
4 |
12 |
0.0001604 |
0.0006909 |
1078 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
4 |
12 |
0.0001604 |
0.0006909 |
1079 |
NEGATIVE REGULATION OF RECEPTOR BINDING |
4 |
12 |
0.0001604 |
0.0006909 |
1080 |
POSITIVE REGULATION OF CAMP MEDIATED SIGNALING |
4 |
12 |
0.0001604 |
0.0006909 |
1081 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
25 |
448 |
0.0001612 |
0.0006939 |
1082 |
REGULATION OF CELL KILLING |
8 |
63 |
0.0001626 |
0.0006993 |
1083 |
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION |
10 |
98 |
0.0001653 |
0.0007093 |
1084 |
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS |
9 |
80 |
0.0001655 |
0.0007093 |
1085 |
COVALENT CHROMATIN MODIFICATION |
21 |
345 |
0.0001654 |
0.0007093 |
1086 |
CELLULAR RESPONSE TO RADIATION |
12 |
137 |
0.0001656 |
0.0007093 |
1087 |
HORMONE MEDIATED SIGNALING PATHWAY |
13 |
158 |
0.0001682 |
0.0007202 |
1088 |
RESPONSE TO AMINE |
7 |
48 |
0.0001731 |
0.0007388 |
1089 |
REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
7 |
48 |
0.0001731 |
0.0007388 |
1090 |
REGULATION OF INTERLEUKIN 2 PRODUCTION |
7 |
48 |
0.0001731 |
0.0007388 |
1091 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
5 |
22 |
0.0001739 |
0.0007412 |
1092 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
5 |
22 |
0.0001739 |
0.0007412 |
1093 |
MAINTENANCE OF LOCATION |
12 |
138 |
0.0001773 |
0.0007541 |
1094 |
CELL CYCLE G2 M PHASE TRANSITION |
12 |
138 |
0.0001773 |
0.0007541 |
1095 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
10 |
99 |
0.0001798 |
0.0007635 |
1096 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
10 |
99 |
0.0001798 |
0.0007635 |
1097 |
POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
8 |
64 |
0.0001819 |
0.0007714 |
1098 |
REGULATION OF CELL SHAPE |
12 |
139 |
0.0001898 |
0.0008042 |
1099 |
SECOND MESSENGER MEDIATED SIGNALING |
13 |
160 |
0.0001907 |
0.0008072 |
1100 |
CELL MATRIX ADHESION |
11 |
119 |
0.0001916 |
0.0008103 |
1101 |
METENCEPHALON DEVELOPMENT |
10 |
100 |
0.0001954 |
0.0008252 |
1102 |
MITOTIC DNA INTEGRITY CHECKPOINT |
10 |
100 |
0.0001954 |
0.0008252 |
1103 |
ACTIN FILAMENT BUNDLE ORGANIZATION |
7 |
49 |
0.0001976 |
0.0008322 |
1104 |
CARDIAC SEPTUM MORPHOGENESIS |
7 |
49 |
0.0001976 |
0.0008322 |
1105 |
CARDIAC CELL DEVELOPMENT |
7 |
49 |
0.0001976 |
0.0008322 |
1106 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
9 |
82 |
0.0002002 |
0.0008421 |
1107 |
REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
15 |
205 |
0.0002017 |
0.0008478 |
1108 |
NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION |
6 |
35 |
0.0002032 |
0.0008517 |
1109 |
POSITIVE REGULATION OF HEART CONTRACTION |
6 |
35 |
0.0002032 |
0.0008517 |
1110 |
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
6 |
35 |
0.0002032 |
0.0008517 |
1111 |
KERATINOCYTE DIFFERENTIATION |
10 |
101 |
0.0002122 |
0.0008871 |
1112 |
REGULATION OF EXTENT OF CELL GROWTH |
10 |
101 |
0.0002122 |
0.0008871 |
1113 |
CAMERA TYPE EYE MORPHOGENESIS |
10 |
101 |
0.0002122 |
0.0008871 |
1114 |
ORGANOPHOSPHATE METABOLIC PROCESS |
40 |
885 |
0.0002151 |
0.0008984 |
1115 |
PROSTATE GLAND MORPHOGENESIS |
5 |
23 |
0.0002177 |
0.0009054 |
1116 |
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
5 |
23 |
0.0002177 |
0.0009054 |
1117 |
REGULATION OF CAMP MEDIATED SIGNALING |
5 |
23 |
0.0002177 |
0.0009054 |
1118 |
RESPONSE TO AUDITORY STIMULUS |
5 |
23 |
0.0002177 |
0.0009054 |
1119 |
POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS |
5 |
23 |
0.0002177 |
0.0009054 |
1120 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
14 |
184 |
0.000218 |
0.0009055 |
1121 |
NIK NF KAPPAB SIGNALING |
9 |
83 |
0.0002197 |
0.0009117 |
1122 |
GAMETE GENERATION |
30 |
595 |
0.0002212 |
0.0009171 |
1123 |
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS |
4 |
13 |
0.0002271 |
0.0009294 |
1124 |
WHITE FAT CELL DIFFERENTIATION |
4 |
13 |
0.0002271 |
0.0009294 |
1125 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
4 |
13 |
0.0002271 |
0.0009294 |
1126 |
REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE |
4 |
13 |
0.0002271 |
0.0009294 |
1127 |
POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS |
4 |
13 |
0.0002271 |
0.0009294 |
1128 |
REGULATION OF MULTICELLULAR ORGANISM GROWTH |
8 |
66 |
0.000226 |
0.0009294 |
1129 |
REGULATION OF REGULATORY T CELL DIFFERENTIATION |
4 |
13 |
0.0002271 |
0.0009294 |
1130 |
RESPONSE TO PARATHYROID HORMONE |
4 |
13 |
0.0002271 |
0.0009294 |
1131 |
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY |
4 |
13 |
0.0002271 |
0.0009294 |
1132 |
RESPONSE TO COBALT ION |
4 |
13 |
0.0002271 |
0.0009294 |
1133 |
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS |
4 |
13 |
0.0002271 |
0.0009294 |
1134 |
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT |
4 |
13 |
0.0002271 |
0.0009294 |
1135 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
7 |
50 |
0.0002249 |
0.0009294 |
1136 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
13 |
0.0002271 |
0.0009294 |
1137 |
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY |
4 |
13 |
0.0002271 |
0.0009294 |
1138 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
10 |
102 |
0.0002301 |
0.0009409 |
1139 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
6 |
36 |
0.0002387 |
0.000971 |
1140 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
11 |
122 |
0.0002385 |
0.000971 |
1141 |
CELL CYCLE PHASE TRANSITION |
17 |
255 |
0.000238 |
0.000971 |
1142 |
NEGATIVE REGULATION OF HISTONE MODIFICATION |
6 |
36 |
0.0002387 |
0.000971 |
1143 |
NEGATIVE REGULATION OF BLOOD CIRCULATION |
6 |
36 |
0.0002387 |
0.000971 |
1144 |
POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION |
6 |
36 |
0.0002387 |
0.000971 |
1145 |
PROTEIN OLIGOMERIZATION |
24 |
434 |
0.0002479 |
0.001008 |
1146 |
NEURON FATE COMMITMENT |
8 |
67 |
0.0002511 |
0.00102 |
1147 |
RESPONSE TO AMMONIUM ION |
7 |
51 |
0.0002552 |
0.001032 |
1148 |
POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
7 |
51 |
0.0002552 |
0.001032 |
1149 |
CELLULAR RESPONSE TO FATTY ACID |
7 |
51 |
0.0002552 |
0.001032 |
1150 |
HOMOTYPIC CELL CELL ADHESION |
7 |
51 |
0.0002552 |
0.001032 |
1151 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
7 |
51 |
0.0002552 |
0.001032 |
1152 |
PALATE DEVELOPMENT |
9 |
85 |
0.0002634 |
0.001064 |
1153 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
12 |
144 |
0.0002639 |
0.001065 |
1154 |
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS |
5 |
24 |
0.0002694 |
0.001085 |
1155 |
POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION |
5 |
24 |
0.0002694 |
0.001085 |
1156 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
8 |
68 |
0.0002785 |
0.001117 |
1157 |
RESPONSE TO NERVE GROWTH FACTOR |
6 |
37 |
0.000279 |
0.001117 |
1158 |
POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY |
6 |
37 |
0.000279 |
0.001117 |
1159 |
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
6 |
37 |
0.000279 |
0.001117 |
1160 |
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
6 |
37 |
0.000279 |
0.001117 |
1161 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
8 |
68 |
0.0002785 |
0.001117 |
1162 |
SINGLE ORGANISM CATABOLIC PROCESS |
42 |
957 |
0.0002788 |
0.001117 |
1163 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
7 |
52 |
0.0002887 |
0.001151 |
1164 |
NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
7 |
52 |
0.0002887 |
0.001151 |
1165 |
NEGATIVE REGULATION OF T CELL PROLIFERATION |
7 |
52 |
0.0002887 |
0.001151 |
1166 |
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
7 |
52 |
0.0002887 |
0.001151 |
1167 |
RESPONSE TO FUNGUS |
7 |
52 |
0.0002887 |
0.001151 |
1168 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
12 |
146 |
0.0002998 |
0.001194 |
1169 |
RESPONSE TO ACTIVITY |
8 |
69 |
0.0003083 |
0.001227 |
1170 |
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT |
4 |
14 |
0.0003117 |
0.001231 |
1171 |
LAYER FORMATION IN CEREBRAL CORTEX |
4 |
14 |
0.0003117 |
0.001231 |
1172 |
NEGATIVE REGULATION OF JUN KINASE ACTIVITY |
4 |
14 |
0.0003117 |
0.001231 |
1173 |
ATRIAL SEPTUM MORPHOGENESIS |
4 |
14 |
0.0003117 |
0.001231 |
1174 |
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
4 |
14 |
0.0003117 |
0.001231 |
1175 |
RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE |
4 |
14 |
0.0003117 |
0.001231 |
1176 |
METANEPHRIC MESENCHYME DEVELOPMENT |
4 |
14 |
0.0003117 |
0.001231 |
1177 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
4 |
14 |
0.0003117 |
0.001231 |
1178 |
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
14 |
0.0003117 |
0.001231 |
1179 |
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
9 |
87 |
0.000314 |
0.001239 |
1180 |
CARDIAC VENTRICLE DEVELOPMENT |
10 |
106 |
0.000315 |
0.001242 |
1181 |
LYMPHOCYTE MEDIATED IMMUNITY |
12 |
147 |
0.0003193 |
0.001257 |
1182 |
REGIONALIZATION |
19 |
311 |
0.0003192 |
0.001257 |
1183 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
15 |
214 |
0.0003207 |
0.001262 |
1184 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
6 |
38 |
0.0003244 |
0.001274 |
1185 |
POSITIVE REGULATION OF ORGAN GROWTH |
6 |
38 |
0.0003244 |
0.001274 |
1186 |
REGULATION OF BLOOD PRESSURE |
13 |
169 |
0.0003262 |
0.00128 |
1187 |
LENS FIBER CELL DIFFERENTIATION |
5 |
25 |
0.00033 |
0.001288 |
1188 |
MEMBRANE ASSEMBLY |
5 |
25 |
0.00033 |
0.001288 |
1189 |
CELLULAR EXTRAVASATION |
5 |
25 |
0.00033 |
0.001288 |
1190 |
HISTONE PHOSPHORYLATION |
5 |
25 |
0.00033 |
0.001288 |
1191 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
5 |
25 |
0.00033 |
0.001288 |
1192 |
THYROID GLAND DEVELOPMENT |
5 |
25 |
0.00033 |
0.001288 |
1193 |
PEPTIDYL LYSINE MODIFICATION |
19 |
312 |
0.0003323 |
0.001296 |
1194 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
11 |
127 |
0.0003384 |
0.001319 |
1195 |
PLATELET DEGRANULATION |
10 |
107 |
0.0003399 |
0.001323 |
1196 |
MALE SEX DIFFERENTIATION |
12 |
148 |
0.0003398 |
0.001323 |
1197 |
OVULATION CYCLE PROCESS |
9 |
88 |
0.0003422 |
0.00133 |
1198 |
NEGATIVE REGULATION OF CELL GROWTH |
13 |
170 |
0.0003453 |
0.001341 |
1199 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
14 |
193 |
0.0003559 |
0.001381 |
1200 |
REGULATION OF PHOSPHATASE ACTIVITY |
11 |
128 |
0.000362 |
0.001404 |
1201 |
POSITIVE REGULATION OF CAMP METABOLIC PROCESS |
9 |
89 |
0.0003725 |
0.001443 |
1202 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
6 |
39 |
0.0003754 |
0.001451 |
1203 |
TRABECULA MORPHOGENESIS |
6 |
39 |
0.0003754 |
0.001451 |
1204 |
CELLULAR RESPONSE TO NUTRIENT |
6 |
39 |
0.0003754 |
0.001451 |
1205 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
13 |
172 |
0.0003866 |
0.001493 |
1206 |
REGULATION OF MITOCHONDRION ORGANIZATION |
15 |
218 |
0.0003905 |
0.001507 |
1207 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
14 |
195 |
0.000395 |
0.001523 |
1208 |
REGULATION OF TYPE 2 IMMUNE RESPONSE |
5 |
26 |
0.0004002 |
0.001529 |
1209 |
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY |
5 |
26 |
0.0004002 |
0.001529 |
1210 |
REGULATION OF MESONEPHROS DEVELOPMENT |
5 |
26 |
0.0004002 |
0.001529 |
1211 |
REPLACEMENT OSSIFICATION |
5 |
26 |
0.0004002 |
0.001529 |
1212 |
CELLULAR RESPONSE TO INTERLEUKIN 4 |
5 |
26 |
0.0004002 |
0.001529 |
1213 |
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
5 |
26 |
0.0004002 |
0.001529 |
1214 |
POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE |
5 |
26 |
0.0004002 |
0.001529 |
1215 |
MESODERMAL CELL DIFFERENTIATION |
5 |
26 |
0.0004002 |
0.001529 |
1216 |
ENDOCHONDRAL OSSIFICATION |
5 |
26 |
0.0004002 |
0.001529 |
1217 |
CELLULAR RESPONSE TO VITAMIN |
5 |
26 |
0.0004002 |
0.001529 |
1218 |
MYELOID DENDRITIC CELL ACTIVATION |
5 |
26 |
0.0004002 |
0.001529 |
1219 |
NAD METABOLIC PROCESS |
7 |
55 |
0.0004106 |
0.001566 |
1220 |
NATURAL KILLER CELL ACTIVATION |
7 |
55 |
0.0004106 |
0.001566 |
1221 |
RESPONSE TO MURAMYL DIPEPTIDE |
4 |
15 |
0.0004167 |
0.001578 |
1222 |
NEGATIVE REGULATION OF HISTONE ACETYLATION |
4 |
15 |
0.0004167 |
0.001578 |
1223 |
POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS |
4 |
15 |
0.0004167 |
0.001578 |
1224 |
JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY |
4 |
15 |
0.0004167 |
0.001578 |
1225 |
MUSCLE CELL FATE COMMITMENT |
4 |
15 |
0.0004167 |
0.001578 |
1226 |
STRIATED MUSCLE CELL PROLIFERATION |
4 |
15 |
0.0004167 |
0.001578 |
1227 |
CHRONIC INFLAMMATORY RESPONSE |
4 |
15 |
0.0004167 |
0.001578 |
1228 |
RESPONSE TO HYDROPEROXIDE |
4 |
15 |
0.0004167 |
0.001578 |
1229 |
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
14 |
196 |
0.0004159 |
0.001578 |
1230 |
NEURON MIGRATION |
10 |
110 |
0.0004247 |
0.001607 |
1231 |
HINDBRAIN MORPHOGENESIS |
6 |
40 |
0.0004325 |
0.001632 |
1232 |
ACTIN FILAMENT ORGANIZATION |
13 |
174 |
0.000432 |
0.001632 |
1233 |
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
6 |
40 |
0.0004325 |
0.001632 |
1234 |
LEARNING |
11 |
131 |
0.0004416 |
0.001665 |
1235 |
HIPPOCAMPUS DEVELOPMENT |
8 |
73 |
0.0004545 |
0.001712 |
1236 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
10 |
111 |
0.0004566 |
0.001719 |
1237 |
CARBOXYLIC ACID BIOSYNTHETIC PROCESS |
17 |
270 |
0.0004615 |
0.001735 |
1238 |
ORGANIC ACID BIOSYNTHETIC PROCESS |
17 |
270 |
0.0004615 |
0.001735 |
1239 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
9 |
92 |
0.0004768 |
0.001791 |
1240 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
5 |
27 |
0.0004812 |
0.001796 |
1241 |
POSITIVE REGULATION OF NEUTROPHIL MIGRATION |
5 |
27 |
0.0004812 |
0.001796 |
1242 |
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
27 |
0.0004812 |
0.001796 |
1243 |
FATTY ACID METABOLIC PROCESS |
18 |
296 |
0.0004806 |
0.001796 |
1244 |
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
27 |
0.0004812 |
0.001796 |
1245 |
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS |
5 |
27 |
0.0004812 |
0.001796 |
1246 |
POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
5 |
27 |
0.0004812 |
0.001796 |
1247 |
HETEROTYPIC CELL CELL ADHESION |
5 |
27 |
0.0004812 |
0.001796 |
1248 |
REGULATION OF LIPID STORAGE |
6 |
41 |
0.0004961 |
0.001847 |
1249 |
TRANSLESION SYNTHESIS |
6 |
41 |
0.0004961 |
0.001847 |
1250 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
6 |
41 |
0.0004961 |
0.001847 |
1251 |
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
7 |
57 |
0.0005126 |
0.001905 |
1252 |
APOPTOTIC MITOCHONDRIAL CHANGES |
7 |
57 |
0.0005126 |
0.001905 |
1253 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
9 |
93 |
0.0005165 |
0.001918 |
1254 |
MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST |
4 |
16 |
0.0005447 |
0.002013 |
1255 |
CARDIAC MYOFIBRIL ASSEMBLY |
4 |
16 |
0.0005447 |
0.002013 |
1256 |
REGULATION OF MACROPHAGE CHEMOTAXIS |
4 |
16 |
0.0005447 |
0.002013 |
1257 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
4 |
16 |
0.0005447 |
0.002013 |
1258 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
4 |
16 |
0.0005447 |
0.002013 |
1259 |
MONOCYTE DIFFERENTIATION |
4 |
16 |
0.0005447 |
0.002013 |
1260 |
REGULATION OF DNA REPAIR |
8 |
75 |
0.0005462 |
0.002016 |
1261 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
8 |
75 |
0.0005462 |
0.002016 |
1262 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
10 |
114 |
0.0005643 |
0.002079 |
1263 |
REGULATION OF EMBRYONIC DEVELOPMENT |
10 |
114 |
0.0005643 |
0.002079 |
1264 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
6 |
42 |
0.0005668 |
0.002085 |
1265 |
REGULATION OF NIK NF KAPPAB SIGNALING |
6 |
42 |
0.0005668 |
0.002085 |
1266 |
REGULATION OF DNA RECOMBINATION |
7 |
58 |
0.0005707 |
0.002093 |
1267 |
POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
5 |
28 |
0.000574 |
0.002093 |
1268 |
NECROTIC CELL DEATH |
5 |
28 |
0.000574 |
0.002093 |
1269 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
11 |
135 |
0.0005701 |
0.002093 |
1270 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
5 |
28 |
0.000574 |
0.002093 |
1271 |
REGULATION OF NEUROBLAST PROLIFERATION |
5 |
28 |
0.000574 |
0.002093 |
1272 |
LONG TERM MEMORY |
5 |
28 |
0.000574 |
0.002093 |
1273 |
T CELL MEDIATED IMMUNITY |
5 |
28 |
0.000574 |
0.002093 |
1274 |
REGULATION OF SPROUTING ANGIOGENESIS |
5 |
28 |
0.000574 |
0.002093 |
1275 |
RESPONSE TO GONADOTROPIN |
5 |
28 |
0.000574 |
0.002093 |
1276 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
5 |
28 |
0.000574 |
0.002093 |
1277 |
GLIAL CELL DEVELOPMENT |
8 |
76 |
0.0005974 |
0.002177 |
1278 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
9 |
95 |
0.0006039 |
0.002199 |
1279 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
11 |
136 |
0.0006066 |
0.002207 |
1280 |
REGULATION OF DEPHOSPHORYLATION |
12 |
158 |
0.0006137 |
0.002231 |
1281 |
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
7 |
59 |
0.0006338 |
0.002302 |
1282 |
HINDBRAIN DEVELOPMENT |
11 |
137 |
0.0006452 |
0.002338 |
1283 |
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
6 |
43 |
0.000645 |
0.002338 |
1284 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
6 |
43 |
0.000645 |
0.002338 |
1285 |
FEMALE SEX DIFFERENTIATION |
10 |
116 |
0.0006472 |
0.002344 |
1286 |
STEM CELL DIVISION |
5 |
29 |
0.0006795 |
0.002455 |
1287 |
POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING |
5 |
29 |
0.0006795 |
0.002455 |
1288 |
REGULATION OF THE FORCE OF HEART CONTRACTION |
5 |
29 |
0.0006795 |
0.002455 |
1289 |
MICROTUBULE BASED PROCESS |
26 |
522 |
0.0006852 |
0.002474 |
1290 |
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT |
4 |
17 |
0.0006984 |
0.002502 |
1291 |
BRANCH ELONGATION OF AN EPITHELIUM |
4 |
17 |
0.0006984 |
0.002502 |
1292 |
POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
0.0006984 |
0.002502 |
1293 |
HEXOSE TRANSMEMBRANE TRANSPORT |
4 |
17 |
0.0006984 |
0.002502 |
1294 |
NEGATIVE REGULATION OF CELL AGING |
4 |
17 |
0.0006984 |
0.002502 |
1295 |
REGULATION OF PLATELET AGGREGATION |
4 |
17 |
0.0006984 |
0.002502 |
1296 |
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
4 |
17 |
0.0006984 |
0.002502 |
1297 |
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
4 |
17 |
0.0006984 |
0.002502 |
1298 |
GLUCOSE TRANSMEMBRANE TRANSPORT |
4 |
17 |
0.0006984 |
0.002502 |
1299 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
0.0006984 |
0.002502 |
1300 |
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
7 |
60 |
0.0007024 |
0.002512 |
1301 |
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY |
7 |
60 |
0.0007024 |
0.002512 |
1302 |
TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY |
10 |
118 |
0.00074 |
0.002644 |
1303 |
MEMORY |
9 |
98 |
0.0007576 |
0.002703 |
1304 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
9 |
98 |
0.0007576 |
0.002703 |
1305 |
NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
7 |
61 |
0.0007767 |
0.002769 |
1306 |
MITOTIC NUCLEAR DIVISION |
20 |
361 |
0.0007779 |
0.002772 |
1307 |
REGULATION OF PEPTIDE SECRETION |
14 |
209 |
0.0007866 |
0.0028 |
1308 |
GLUCOSE METABOLIC PROCESS |
10 |
119 |
0.0007903 |
0.002809 |
1309 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
10 |
119 |
0.0007903 |
0.002809 |
1310 |
SMALL MOLECULE BIOSYNTHETIC PROCESS |
23 |
443 |
0.0007914 |
0.002811 |
1311 |
POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION |
5 |
30 |
0.0007989 |
0.002822 |
1312 |
MEMBRANE BIOGENESIS |
5 |
30 |
0.0007989 |
0.002822 |
1313 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
5 |
30 |
0.0007989 |
0.002822 |
1314 |
BLASTOCYST FORMATION |
5 |
30 |
0.0007989 |
0.002822 |
1315 |
BROWN FAT CELL DIFFERENTIATION |
5 |
30 |
0.0007989 |
0.002822 |
1316 |
RESPONSE TO ATP |
5 |
30 |
0.0007989 |
0.002822 |
1317 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
5 |
30 |
0.0007989 |
0.002822 |
1318 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
9 |
99 |
0.0008154 |
0.002879 |
1319 |
ENDOTHELIAL CELL DEVELOPMENT |
6 |
45 |
0.0008264 |
0.002909 |
1320 |
POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION |
6 |
45 |
0.0008264 |
0.002909 |
1321 |
REGULATION OF EPIDERMAL CELL DIFFERENTIATION |
6 |
45 |
0.0008264 |
0.002909 |
1322 |
SMOOTH MUSCLE CONTRACTION |
6 |
45 |
0.0008264 |
0.002909 |
1323 |
REGULATION OF DENDRITE DEVELOPMENT |
10 |
120 |
0.0008434 |
0.002966 |
1324 |
DEFENSE RESPONSE TO VIRUS |
12 |
164 |
0.0008535 |
0.002999 |
1325 |
BLASTOCYST DEVELOPMENT |
7 |
62 |
0.0008571 |
0.00301 |
1326 |
ATRIAL SEPTUM DEVELOPMENT |
4 |
18 |
0.0008804 |
0.00308 |
1327 |
RESPONSE TO CAFFEINE |
4 |
18 |
0.0008804 |
0.00308 |
1328 |
KIDNEY MESENCHYME DEVELOPMENT |
4 |
18 |
0.0008804 |
0.00308 |
1329 |
POSITIVE REGULATION OF DNA RECOMBINATION |
4 |
18 |
0.0008804 |
0.00308 |
1330 |
RESPONSE TO WATER |
4 |
18 |
0.0008804 |
0.00308 |
1331 |
ICOSANOID BIOSYNTHETIC PROCESS |
6 |
46 |
0.0009307 |
0.003238 |
1332 |
CARDIAC ATRIUM DEVELOPMENT |
5 |
31 |
0.0009332 |
0.003238 |
1333 |
CEREBELLAR CORTEX DEVELOPMENT |
6 |
46 |
0.0009307 |
0.003238 |
1334 |
REGULATION OF MICROTUBULE POLYMERIZATION |
5 |
31 |
0.0009332 |
0.003238 |
1335 |
PEPTIDYL THREONINE MODIFICATION |
6 |
46 |
0.0009307 |
0.003238 |
1336 |
NEURON FATE SPECIFICATION |
5 |
31 |
0.0009332 |
0.003238 |
1337 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
6 |
46 |
0.0009307 |
0.003238 |
1338 |
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION |
5 |
31 |
0.0009332 |
0.003238 |
1339 |
MISMATCH REPAIR |
5 |
31 |
0.0009332 |
0.003238 |
1340 |
REGULATION OF PLATELET ACTIVATION |
5 |
31 |
0.0009332 |
0.003238 |
1341 |
FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS |
6 |
46 |
0.0009307 |
0.003238 |
1342 |
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
7 |
63 |
0.0009439 |
0.003273 |
1343 |
LOCALIZATION WITHIN MEMBRANE |
10 |
122 |
0.0009584 |
0.00332 |
1344 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
12 |
167 |
0.0009999 |
0.003462 |
1345 |
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY |
7 |
64 |
0.001038 |
0.003584 |
1346 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
7 |
64 |
0.001038 |
0.003584 |
1347 |
REGULATION OF PROTEIN ACETYLATION |
7 |
64 |
0.001038 |
0.003584 |
1348 |
NEURON DEATH |
6 |
47 |
0.001045 |
0.003604 |
1349 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
6 |
47 |
0.001045 |
0.003604 |
1350 |
RESPONSE TO FATTY ACID |
8 |
83 |
0.001074 |
0.003703 |
1351 |
PROSTAGLANDIN BIOSYNTHETIC PROCESS |
4 |
19 |
0.001093 |
0.003714 |
1352 |
NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION |
4 |
19 |
0.001093 |
0.003714 |
1353 |
THYMIC T CELL SELECTION |
4 |
19 |
0.001093 |
0.003714 |
1354 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
4 |
19 |
0.001093 |
0.003714 |
1355 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
19 |
0.001093 |
0.003714 |
1356 |
MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY |
5 |
32 |
0.001084 |
0.003714 |
1357 |
NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
4 |
19 |
0.001093 |
0.003714 |
1358 |
NEGATIVE REGULATION OF ATP METABOLIC PROCESS |
4 |
19 |
0.001093 |
0.003714 |
1359 |
T CELL RECEPTOR SIGNALING PATHWAY |
11 |
146 |
0.001092 |
0.003714 |
1360 |
BLOOD VESSEL REMODELING |
5 |
32 |
0.001084 |
0.003714 |
1361 |
ENTEROENDOCRINE CELL DIFFERENTIATION |
4 |
19 |
0.001093 |
0.003714 |
1362 |
CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS |
4 |
19 |
0.001093 |
0.003714 |
1363 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
5 |
32 |
0.001084 |
0.003714 |
1364 |
ERROR PRONE TRANSLESION SYNTHESIS |
4 |
19 |
0.001093 |
0.003714 |
1365 |
MUSCLE CELL CELLULAR HOMEOSTASIS |
4 |
19 |
0.001093 |
0.003714 |
1366 |
NEGATIVE REGULATION OF T CELL DIFFERENTIATION |
5 |
32 |
0.001084 |
0.003714 |
1367 |
REGULATION OF NEUTROPHIL MIGRATION |
5 |
32 |
0.001084 |
0.003714 |
1368 |
ADIPOSE TISSUE DEVELOPMENT |
5 |
32 |
0.001084 |
0.003714 |
1369 |
PROSTANOID BIOSYNTHETIC PROCESS |
4 |
19 |
0.001093 |
0.003714 |
1370 |
ASTROCYTE DEVELOPMENT |
4 |
19 |
0.001093 |
0.003714 |
1371 |
APPENDAGE DEVELOPMENT |
12 |
169 |
0.001109 |
0.00376 |
1372 |
LIMB DEVELOPMENT |
12 |
169 |
0.001109 |
0.00376 |
1373 |
REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
14 |
217 |
0.001131 |
0.003833 |
1374 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
10 |
125 |
0.001155 |
0.00391 |
1375 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
8 |
84 |
0.001162 |
0.003933 |
1376 |
RESPONSE TO AXON INJURY |
6 |
48 |
0.001169 |
0.003943 |
1377 |
NEGATIVE REGULATION OF COAGULATION |
6 |
48 |
0.001169 |
0.003943 |
1378 |
REGULATION OF LIPID KINASE ACTIVITY |
6 |
48 |
0.001169 |
0.003943 |
1379 |
DIGESTIVE TRACT MORPHOGENESIS |
6 |
48 |
0.001169 |
0.003943 |
1380 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
6 |
48 |
0.001169 |
0.003943 |
1381 |
MALE GAMETE GENERATION |
24 |
486 |
0.001221 |
0.004115 |
1382 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
19 |
348 |
0.001237 |
0.004165 |
1383 |
CELLULAR RESPONSE TO UV |
7 |
66 |
0.001246 |
0.004191 |
1384 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
7 |
66 |
0.001246 |
0.004191 |
1385 |
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
5 |
33 |
0.001251 |
0.004201 |
1386 |
G2 DNA DAMAGE CHECKPOINT |
5 |
33 |
0.001251 |
0.004201 |
1387 |
CARDIAC SEPTUM DEVELOPMENT |
8 |
85 |
0.001256 |
0.004212 |
1388 |
REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
6 |
49 |
0.001305 |
0.004371 |
1389 |
REGULATION OF ATP METABOLIC PROCESS |
6 |
49 |
0.001305 |
0.004371 |
1390 |
CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION |
4 |
20 |
0.00134 |
0.004454 |
1391 |
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
4 |
20 |
0.00134 |
0.004454 |
1392 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
4 |
20 |
0.00134 |
0.004454 |
1393 |
ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION |
4 |
20 |
0.00134 |
0.004454 |
1394 |
CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS |
4 |
20 |
0.00134 |
0.004454 |
1395 |
TELENCEPHALON GLIAL CELL MIGRATION |
4 |
20 |
0.00134 |
0.004454 |
1396 |
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS |
4 |
20 |
0.00134 |
0.004454 |
1397 |
MEGAKARYOCYTE DIFFERENTIATION |
4 |
20 |
0.00134 |
0.004454 |
1398 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN |
4 |
20 |
0.00134 |
0.004454 |
1399 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
20 |
0.00134 |
0.004454 |
1400 |
RESPONSE TO LEAD ION |
4 |
20 |
0.00134 |
0.004454 |
1401 |
REGULATION OF HEART CONTRACTION |
14 |
221 |
0.001346 |
0.00447 |
1402 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
7 |
67 |
0.001363 |
0.004519 |
1403 |
REGULATION OF NOTCH SIGNALING PATHWAY |
7 |
67 |
0.001363 |
0.004519 |
1404 |
WNT SIGNALING PATHWAY |
19 |
351 |
0.001366 |
0.004527 |
1405 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
34 |
0.001437 |
0.004747 |
1406 |
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
34 |
0.001437 |
0.004747 |
1407 |
ER NUCLEUS SIGNALING PATHWAY |
5 |
34 |
0.001437 |
0.004747 |
1408 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
5 |
34 |
0.001437 |
0.004747 |
1409 |
NEGATIVE REGULATION OF MULTI ORGANISM PROCESS |
11 |
151 |
0.001435 |
0.004747 |
1410 |
FACE DEVELOPMENT |
6 |
50 |
0.001452 |
0.004792 |
1411 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
8 |
87 |
0.00146 |
0.004815 |
1412 |
NUCLEAR IMPORT |
10 |
129 |
0.001466 |
0.004825 |
1413 |
CELL JUNCTION ASSEMBLY |
10 |
129 |
0.001466 |
0.004825 |
1414 |
REGULATION OF CAMP METABOLIC PROCESS |
10 |
129 |
0.001466 |
0.004825 |
1415 |
ORGAN GROWTH |
7 |
68 |
0.001487 |
0.00489 |
1416 |
METANEPHRIC NEPHRON MORPHOGENESIS |
4 |
21 |
0.001623 |
0.005289 |
1417 |
NECROPTOTIC PROCESS |
4 |
21 |
0.001623 |
0.005289 |
1418 |
REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
4 |
21 |
0.001623 |
0.005289 |
1419 |
CHONDROCYTE DEVELOPMENT |
4 |
21 |
0.001623 |
0.005289 |
1420 |
DECIDUALIZATION |
4 |
21 |
0.001623 |
0.005289 |
1421 |
NEURAL CREST CELL MIGRATION |
6 |
51 |
0.001612 |
0.005289 |
1422 |
POSITIVE T CELL SELECTION |
4 |
21 |
0.001623 |
0.005289 |
1423 |
VIRAL GENOME REPLICATION |
4 |
21 |
0.001623 |
0.005289 |
1424 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
4 |
21 |
0.001623 |
0.005289 |
1425 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
6 |
51 |
0.001612 |
0.005289 |
1426 |
NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
4 |
21 |
0.001623 |
0.005289 |
1427 |
NEGATIVE REGULATION OF PROTEIN ACETYLATION |
4 |
21 |
0.001623 |
0.005289 |
1428 |
POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
9 |
109 |
0.001615 |
0.005289 |
1429 |
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS |
5 |
35 |
0.001643 |
0.005328 |
1430 |
NADH METABOLIC PROCESS |
5 |
35 |
0.001643 |
0.005328 |
1431 |
MEMBRANE PROTEIN PROTEOLYSIS |
5 |
35 |
0.001643 |
0.005328 |
1432 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS |
5 |
35 |
0.001643 |
0.005328 |
1433 |
RESPONSE TO IRON ION |
5 |
35 |
0.001643 |
0.005328 |
1434 |
RESPONSE TO MONOAMINE |
5 |
35 |
0.001643 |
0.005328 |
1435 |
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES |
5 |
35 |
0.001643 |
0.005328 |
1436 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
61 |
1676 |
0.001742 |
0.005642 |
1437 |
POSITIVE REGULATION OF CELL DIVISION |
10 |
132 |
0.001742 |
0.005642 |
1438 |
MUSCLE ORGAN MORPHOGENESIS |
7 |
70 |
0.001762 |
0.005698 |
1439 |
REGULATION OF MEMBRANE PERMEABILITY |
7 |
70 |
0.001762 |
0.005698 |
1440 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
11 |
155 |
0.001769 |
0.005717 |
1441 |
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
52 |
0.001784 |
0.005762 |
1442 |
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
9 |
111 |
0.001833 |
0.00591 |
1443 |
NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
9 |
111 |
0.001833 |
0.00591 |
1444 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
5 |
36 |
0.00187 |
0.006008 |
1445 |
POSITIVE REGULATION OF AXON EXTENSION |
5 |
36 |
0.00187 |
0.006008 |
1446 |
CELLULAR RESPONSE TO HEAT |
5 |
36 |
0.00187 |
0.006008 |
1447 |
TOXIN TRANSPORT |
5 |
36 |
0.00187 |
0.006008 |
1448 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
5 |
36 |
0.00187 |
0.006008 |
1449 |
CELL FATE SPECIFICATION |
7 |
71 |
0.001914 |
0.006146 |
1450 |
CELLULAR RESPONSE TO VIRUS |
4 |
22 |
0.001945 |
0.006208 |
1451 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
4 |
22 |
0.001945 |
0.006208 |
1452 |
BONE CELL DEVELOPMENT |
4 |
22 |
0.001945 |
0.006208 |
1453 |
SEX DETERMINATION |
4 |
22 |
0.001945 |
0.006208 |
1454 |
POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION |
4 |
22 |
0.001945 |
0.006208 |
1455 |
REGULATION OF CELLULAR EXTRAVASATION |
4 |
22 |
0.001945 |
0.006208 |
1456 |
REGULATION OF T CELL CYTOKINE PRODUCTION |
4 |
22 |
0.001945 |
0.006208 |
1457 |
EMBRYONIC PLACENTA MORPHOGENESIS |
4 |
22 |
0.001945 |
0.006208 |
1458 |
HISTONE H3 DEACETYLATION |
4 |
22 |
0.001945 |
0.006208 |
1459 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
8 |
91 |
0.001949 |
0.00621 |
1460 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
10 |
134 |
0.001949 |
0.00621 |
1461 |
OXIDATION REDUCTION PROCESS |
37 |
898 |
0.001959 |
0.006234 |
1462 |
HEXOSE METABOLIC PROCESS |
11 |
157 |
0.001959 |
0.006234 |
1463 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
6 |
53 |
0.001971 |
0.006263 |
1464 |
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
6 |
53 |
0.001971 |
0.006263 |
1465 |
FC RECEPTOR SIGNALING PATHWAY |
13 |
206 |
0.00204 |
0.00648 |
1466 |
CELL GROWTH |
10 |
135 |
0.002059 |
0.006535 |
1467 |
PHOSPHOLIPID METABOLIC PROCESS |
19 |
364 |
0.002066 |
0.006554 |
1468 |
URETER DEVELOPMENT |
3 |
11 |
0.002181 |
0.006807 |
1469 |
REGULATION OF CHOLESTEROL HOMEOSTASIS |
3 |
11 |
0.002181 |
0.006807 |
1470 |
NEGATIVE REGULATION OF SODIUM ION TRANSPORT |
3 |
11 |
0.002181 |
0.006807 |
1471 |
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS |
3 |
11 |
0.002181 |
0.006807 |
1472 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE |
3 |
11 |
0.002181 |
0.006807 |
1473 |
POSTREPLICATION REPAIR |
6 |
54 |
0.002171 |
0.006807 |
1474 |
VENTRAL SPINAL CORD INTERNEURON SPECIFICATION |
3 |
11 |
0.002181 |
0.006807 |
1475 |
RESPONSE TO GRAVITY |
3 |
11 |
0.002181 |
0.006807 |
1476 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
3 |
11 |
0.002181 |
0.006807 |
1477 |
REGULATION OF CHRONIC INFLAMMATORY RESPONSE |
3 |
11 |
0.002181 |
0.006807 |
1478 |
SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT |
3 |
11 |
0.002181 |
0.006807 |
1479 |
MONOSACCHARIDE TRANSPORT |
6 |
54 |
0.002171 |
0.006807 |
1480 |
REGULATION OF PHOSPHOLIPASE A2 ACTIVITY |
3 |
11 |
0.002181 |
0.006807 |
1481 |
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS |
3 |
11 |
0.002181 |
0.006807 |
1482 |
CYCLOOXYGENASE PATHWAY |
3 |
11 |
0.002181 |
0.006807 |
1483 |
NEGATIVE REGULATION OF CELLULAR SENESCENCE |
3 |
11 |
0.002181 |
0.006807 |
1484 |
NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS |
3 |
11 |
0.002181 |
0.006807 |
1485 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
6 |
54 |
0.002171 |
0.006807 |
1486 |
POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION |
3 |
11 |
0.002181 |
0.006807 |
1487 |
NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS |
3 |
11 |
0.002181 |
0.006807 |
1488 |
REGULATION OF INTERFERON GAMMA SECRETION |
3 |
11 |
0.002181 |
0.006807 |
1489 |
CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION |
3 |
11 |
0.002181 |
0.006807 |
1490 |
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS |
3 |
11 |
0.002181 |
0.006807 |
1491 |
NEGATIVE REGULATION OF NECROTIC CELL DEATH |
3 |
11 |
0.002181 |
0.006807 |
1492 |
RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
14 |
233 |
0.002205 |
0.006867 |
1493 |
MUSCLE CONTRACTION |
14 |
233 |
0.002205 |
0.006867 |
1494 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
9 |
114 |
0.002203 |
0.006867 |
1495 |
EMBRYONIC HEART TUBE DEVELOPMENT |
7 |
73 |
0.002247 |
0.00699 |
1496 |
G1 DNA DAMAGE CHECKPOINT |
7 |
73 |
0.002247 |
0.00699 |
1497 |
DNA REPAIR |
23 |
480 |
0.002249 |
0.006992 |
1498 |
ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT |
4 |
23 |
0.002309 |
0.007133 |
1499 |
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION |
4 |
23 |
0.002309 |
0.007133 |
1500 |
REGULATION OF OSTEOBLAST PROLIFERATION |
4 |
23 |
0.002309 |
0.007133 |
1501 |
EPIBOLY |
4 |
23 |
0.002309 |
0.007133 |
1502 |
ACTIN FILAMENT POLYMERIZATION |
4 |
23 |
0.002309 |
0.007133 |
1503 |
TRABECULA FORMATION |
4 |
23 |
0.002309 |
0.007133 |
1504 |
STRIATED MUSCLE ADAPTATION |
4 |
23 |
0.002309 |
0.007133 |
1505 |
POSITIVE REGULATION OF STEROID METABOLIC PROCESS |
4 |
23 |
0.002309 |
0.007133 |
1506 |
REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
4 |
23 |
0.002309 |
0.007133 |
1507 |
REGULATION OF DOUBLE STRAND BREAK REPAIR |
5 |
38 |
0.00239 |
0.00736 |
1508 |
SPINDLE LOCALIZATION |
5 |
38 |
0.00239 |
0.00736 |
1509 |
POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING |
5 |
38 |
0.00239 |
0.00736 |
1510 |
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
38 |
0.00239 |
0.00736 |
1511 |
CYTOKINE SECRETION |
5 |
38 |
0.00239 |
0.00736 |
1512 |
REGULATION OF DNA BIOSYNTHETIC PROCESS |
8 |
94 |
0.002393 |
0.007363 |
1513 |
REGULATION OF DENDRITE MORPHOGENESIS |
7 |
74 |
0.00243 |
0.007474 |
1514 |
PROTEIN SECRETION |
9 |
116 |
0.002481 |
0.007624 |
1515 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
10 |
139 |
0.002551 |
0.007836 |
1516 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
8 |
95 |
0.002557 |
0.007844 |
1517 |
CANONICAL WNT SIGNALING PATHWAY |
8 |
95 |
0.002557 |
0.007844 |
1518 |
REGULATION OF NUCLEAR DIVISION |
11 |
163 |
0.002627 |
0.00805 |
1519 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
9 |
117 |
0.00263 |
0.00805 |
1520 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
117 |
0.00263 |
0.00805 |
1521 |
ATP GENERATION FROM ADP |
5 |
39 |
0.002686 |
0.008196 |
1522 |
ERBB2 SIGNALING PATHWAY |
5 |
39 |
0.002686 |
0.008196 |
1523 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
5 |
39 |
0.002686 |
0.008196 |
1524 |
COCHLEA DEVELOPMENT |
5 |
39 |
0.002686 |
0.008196 |
1525 |
SPLEEN DEVELOPMENT |
5 |
39 |
0.002686 |
0.008196 |
1526 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
4 |
24 |
0.002717 |
0.008256 |
1527 |
RESPONSE TO STEROL |
4 |
24 |
0.002717 |
0.008256 |
1528 |
SPINAL CORD PATTERNING |
4 |
24 |
0.002717 |
0.008256 |
1529 |
REGULATION OF ODONTOGENESIS |
4 |
24 |
0.002717 |
0.008256 |
1530 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
24 |
0.002717 |
0.008256 |
1531 |
ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION |
4 |
24 |
0.002717 |
0.008256 |
1532 |
ICOSANOID METABOLIC PROCESS |
8 |
96 |
0.00273 |
0.008287 |
1533 |
FATTY ACID DERIVATIVE METABOLIC PROCESS |
8 |
96 |
0.00273 |
0.008287 |
1534 |
SINGLE ORGANISM BIOSYNTHETIC PROCESS |
50 |
1340 |
0.002778 |
0.008427 |
1535 |
NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS |
14 |
239 |
0.002781 |
0.008429 |
1536 |
TOLERANCE INDUCTION |
3 |
12 |
0.002855 |
0.008565 |
1537 |
REGULATION OF TIMING OF CELL DIFFERENTIATION |
3 |
12 |
0.002855 |
0.008565 |
1538 |
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS |
3 |
12 |
0.002855 |
0.008565 |
1539 |
CELLULAR RESPONSE TO ATP |
3 |
12 |
0.002855 |
0.008565 |
1540 |
NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
3 |
12 |
0.002855 |
0.008565 |
1541 |
REGULATION OF CHEMOKINE SECRETION |
3 |
12 |
0.002855 |
0.008565 |
1542 |
POST EMBRYONIC MORPHOGENESIS |
3 |
12 |
0.002855 |
0.008565 |
1543 |
REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS |
3 |
12 |
0.002855 |
0.008565 |
1544 |
PERK MEDIATED UNFOLDED PROTEIN RESPONSE |
3 |
12 |
0.002855 |
0.008565 |
1545 |
I KAPPAB PHOSPHORYLATION |
3 |
12 |
0.002855 |
0.008565 |
1546 |
REGULATION OF DEVELOPMENT HETEROCHRONIC |
3 |
12 |
0.002855 |
0.008565 |
1547 |
CELL ADHESION MEDIATED BY INTEGRIN |
3 |
12 |
0.002855 |
0.008565 |
1548 |
RENAL ABSORPTION |
3 |
12 |
0.002855 |
0.008565 |
1549 |
ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY |
3 |
12 |
0.002855 |
0.008565 |
1550 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
3 |
12 |
0.002855 |
0.008565 |
1551 |
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION |
3 |
12 |
0.002855 |
0.008565 |
1552 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
8 |
97 |
0.002913 |
0.008732 |
1553 |
PROTEIN CATABOLIC PROCESS |
26 |
579 |
0.002923 |
0.008759 |
1554 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
5 |
40 |
0.003008 |
0.00899 |
1555 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
5 |
40 |
0.003008 |
0.00899 |
1556 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
40 |
0.003008 |
0.00899 |
1557 |
REGULATION OF FILOPODIUM ASSEMBLY |
5 |
40 |
0.003008 |
0.00899 |
1558 |
REGULATION OF SODIUM ION TRANSPORT |
7 |
77 |
0.003047 |
0.009089 |
1559 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
7 |
77 |
0.003047 |
0.009089 |
1560 |
CELLULAR TRANSITION METAL ION HOMEOSTASIS |
7 |
77 |
0.003047 |
0.009089 |
1561 |
NEGATIVE REGULATION OF WOUND HEALING |
6 |
58 |
0.00313 |
0.009331 |
1562 |
CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS |
4 |
25 |
0.003171 |
0.009399 |
1563 |
DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION |
4 |
25 |
0.003171 |
0.009399 |
1564 |
POSITIVE REGULATION OF COAGULATION |
4 |
25 |
0.003171 |
0.009399 |
1565 |
POSITIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
4 |
25 |
0.003171 |
0.009399 |
1566 |
DOPAMINE METABOLIC PROCESS |
4 |
25 |
0.003171 |
0.009399 |
1567 |
CARBOHYDRATE TRANSMEMBRANE TRANSPORT |
4 |
25 |
0.003171 |
0.009399 |
1568 |
POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
4 |
25 |
0.003171 |
0.009399 |
1569 |
EPITHELIAL CELL APOPTOTIC PROCESS |
4 |
25 |
0.003171 |
0.009399 |
1570 |
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY |
4 |
25 |
0.003171 |
0.009399 |
1571 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
7 |
78 |
0.003278 |
0.009708 |
1572 |
DNA DEPENDENT DNA REPLICATION |
8 |
99 |
0.003305 |
0.009784 |
1573 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
16 |
297 |
0.003323 |
0.009829 |
1574 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
5 |
41 |
0.003357 |
0.009912 |
1575 |
MONOCYTE CHEMOTAXIS |
5 |
41 |
0.003357 |
0.009912 |
1576 |
RECEPTOR CLUSTERING |
5 |
41 |
0.003357 |
0.009912 |